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Title: Molecular Mechanisms of Cytotoxicity Regulation in Pseudomonas aeruginosa by 
the Magnesium Transporter MgtE 
Major Professor: Gregory Anderson 
 
The Gram-negative bacterium Pseudomonas aeruginosa causes numerous acute and 
chronic opportunistic infections in humans. One of its most formidable weapons is a type 
III secretion system (T3SS), a multi-protein molecular syringe that injects powerful toxins 
directly into host cells. The toxins lead to cell dysfunction and, ultimately, cell death. 
Identification of regulatory pathways that control T3SS gene expression may lead to the 
discovery of novel therapeutics to treat P. aeruginosa infections. In a previous study, it was 
found that expression of the magnesium transporter gene mgtE inhibits T3SS gene 
transcription. MgtE-dependent inhibition appeared to interfere with the synthesis or 
function of the master T3SS transcriptional activator ExsA, although the exact mechanism 
was unclear. In this work, we demonstrate that mgtE expression acts through the GacAS 
two-component system to activate transcription of the small regulatory RNAs RsmY and 
RsmZ. This event ultimately leads to inhibition of exsA translation. Moreover, our data 
reveal that MgtE acts solely through this pathway to regulate T3SS gene transcription. Our 
study reveals an important mechanism that may allow P. aeruginosa to fine-tune T3SS 
activity in response to certain environmental stimuli. 
 
In addition, a previous study has shown that the P. aeruginosa gene algR abrogates mgtE 
mediated regulation of cytotoxicity. AlgR has pleiotropic effects in P. aeruginosa, 
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including regulation of synthesis of the exopolysaccharide alginate. In the second part of 
my thesis, I show that algR and mgtE genetically crosstalk to inhibit ExsA driven T3SS 
gene transcription. This genetic interaction between algR and mgtE seems to be specifically 
directed towards regulation of T3SS gene expression rather than having an indiscriminate 
effect on multiple virulence attributes in P. aeruginosa. Additionally, we have further 
demonstrated that AlgR inhibits mgtE transcription. These studies suggest the presence of 
a T3SS inhibitor that is inhibited by both AlgR and MgtE. Future work will involve 
transcriptomic and proteomic analysis to identify such an inhibitor. 
 
Taken together, this study provides important insight into the molecular mechanisms of 
mgtE expression and function in P. aeruginosa. We have established that mgtE has 
pleiotropic effects on cytotoxicity in P. aeruginosa. Thus, given the role that cytotoxicity 
regulation plays in shaping P. aeruginosa pathogenesis and associated clinical outcomes, 
mgtE might be an interesting drug target, though extensive future studies are required to 
validate this proposition. Nevertheless, this research, provides clues for identification of 
novel therapeutic targets in P. aeruginosa. Hence this work, in the long run, serve to 
ameliorate the morbidity and mortality in patients infected with P. aeruginosa.  
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 INTRODUCTION 
This chapter in part, has been published in references (1) and (2). Required permissions 
have been obtained. 
 
Pseudomonas aeruginosa is a Gram-negative pathogen implicated in a multitude of acute 
and chronic infections (3). Like other members of the bacterial genus Pseudomonas, they 
are ubiquitous in soil and water ecosystems (4). Their genetic flexibility, versatility in 
optimizing the usage of a vast array of organic and inorganic compounds, and innate 
capability to survive under diverse, often trying, environmental conditions are the key 
factors behind their successful inhabitation of most environmental niches found on our 
planet. These characteristics also enable them to become notorious opportunistic pathogens. 
From the point of view of mankind, this genus is threatening indeed due to its inherent and 
acquired antibiotic resistance (5). It is not surprising therefore, that it has been increasingly 
implicated in nosocomial infections and deaths (5). This, and its involvement in the 
permanent lung infections in cystic fibrosis patients (described later), which severely 
increase morbidity and mortality, warrants the study of its virulence mechanisms and their 
regulation.  
 
1.1 Taxonomy 
P. aeruginosa is part of the bacterial family Pseudomonadaceae, which is also comprised 
of Azotobacter, Azomonas, Cellvibrio, and Azorhizophilus, among others. 
Pseudomonadaceae are commonly characterized as chemoorganotrophic, aerobic, and 
incapable of photosynthesis. These are also able to survive under a myriad of nutritional 
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environments (6). While the common methods of taxonomical organization of the 
Pseudomonas genus include cell morphology, pigment types, nutritional behaviors, and 
genetic organization (7), the widespread phenotypic characteristics mostly studied are 
carbon utilization patterns, antibiotic resistance, and antibiotic and amino acid synthesis 
(8).  Over 30 species exist in the genus Pseudomonas (7), and 13 species (and numerous 
strains thereof) are sequenced and annotated, P. aeruginosa amongst them. While the 
benefits of chemotaxonomic studies have been widely published (9), it is generally 
accepted that gene sequencing studies hold the greatest promise for solving Pseudomonas 
taxonomic issues (7).  
 
1.2 Cellular Characteristics 
P. aeruginosa is Gram-negative, catalase and oxidase positive. These microbes are slightly 
curved or linear rod-shaped cells, having a maximum length of approximately 4 μm. They 
are often motile via polar flagella, although lateral flagella are occasionally found, usually 
associated with swarming (6, 10). The flagellar number is decided by FleN, a putative 
ATP–GTP binding protein (6). Pili have been reported and are particularly studied for their 
role in pathogenesis in P. aeruginosa (11); nevertheless, other typical nonpathogenic 
Pseudomonas species like P. fluorescens have also been cited to possess pili (12). 
Intriguingly, low G + C content of pilin genes, in relation to the higher average 
chromosomal G + C, indicates horizontal acquisition of pilin genes by Pseudomonas 
species (13). Pseudomonas species produce a number of colored pigments. For instance, 
under limiting iron conditions, they produce iron chelator molecules that fluoresce under 
UV light (14). Other pigments are non-fluorescent and participate in other processes. P. 
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aeruginosa commonly produces the pigments pyocyanin, pyoveridin and pyorubin. 
Intracellularly, Pseudomonas species form inclusion bodies of various substances. For 
instance, under nitrogen-deficient conditions, Pseudomonas accumulates poly-β-
hydroxybutyrate (PHB) granules. When growing on gluconate or alkanes, they are found 
to assemble poly-hydroxyalkanoates. 
 
1.3 Physiology and Metabolism 
As mentioned, P. aeruginosa exhibits great metabolic plasticity (6), and extensive analysis 
has been performed to elucidate Pseudomonas metabolism. The TCA cycle has been 
reported in P. aeruginosa and in all other species of Pseudomonas. The Entner–Doudoroff 
glycolytic pathway often prevails over the Embden–Meyerhof pathway due to the lack of 
6-phosphofructokinase in many species. The Pentose Phosphate pathway, the glyoxylate 
shunt, and other important metabolic pathways are also widespread in this genus. 
Catabolite repression is also reported in Pseudomonas (15, 16), which allows 
Pseudomonas to utilize a medley of available carbon sources in a preferential and orderly 
manner. Organic and amino acids are preferred to glucose (17), followed by mannitol and 
histidine. Catabolite repression is facilitated by Crc and other signal transduction proteins 
(18, 19). Intriguingly, in some cases, like during repression of phenol metabolism in P. 
putida, cells mediate catabolite repression by discerning the redox state of respiratory 
chains. 
 
P. aeruginosa has a propensity to use amino acids as carbon and nitrogen sources. Using 
specific membrane permeases, amino acids available in the environment are translocated 
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into the cell cytoplasm (20). The ability of using amino acids as nutrients poses a great 
advantage to Pseudomonas because amino acids can be readily assimilated into the cell 
biomass with minimal processing. Alternatively, amino acids can be further metabolized 
to enter central metabolism. Among amino acids, arginine metabolism, especially, is key 
in Pseudomonas biochemistry, with a number of catabolic pathways identified for breaking 
down this substrate (21, 22). In P. aeruginosa, numerous arginine-responsive genes are 
controlled by the arginine regulatory protein ArgR (23).  
 
Though typically considered a strict aerobe, P. aeruginosa can perform fermentations 
and/or anaerobic respiration as a facultative anaerobe. Specifically, arginine (24) and 
pyruvate fermentation (24) pathways have been reported. Additionally, it utilizes 
nitrogenous substances, like nitrate, as terminal electron acceptors for anaerobic respiration 
(25).  
 
1.4 Habitat 
P. aeruginosa is ubiquitous in the environment, which is attributed to its metabolic 
versatility (26). It can be found in soil and water environments, as well as plant and animal 
tissues and many other niches. P. aeruginosa cells have even been found in hospital saline 
solutions (27), Antarctic cyanobacterial mats, and in water from plumbing fixtures (28). It 
grows over a temperature range of 4°C–42°C, and pH 4–8 is considered favorable. Though 
culture-dependent studies indicate that P. aeruginosa might be an important soil 
microorganism (29), culture-independent methods, such as metagenomics, suggest that 
Pseudomonas species actually might be relatively scarce in the soil environment. 
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Nevertheless, when growing in soil, Pseudomonas does so in conjunction with other 
bacteria, like Streptomyces, that supply monomeric carbon compounds (6). Pseudomonas 
is considered extremely suited to thriving in the rhizosphere (30), the territory impacted by 
vegetation. Importantly, Pseudomonas outcompetes other microorganisms to optimize 
their hold on the rhizosphere. While some species, like P. syringae, are epiphytic in nature 
and effectively colonize plant leaves and other plant surfaces to cause disease (31), and 
others benefit the plant by producing phytohormones (32), P. aeruginosa is a saprophyte 
or pathogen, found to be scavenging organic matter (33). 
1.5 Control of Gene Expression 
P. aeruginosa has one of the largest genomes among sequenced bacteria, containing over 
6 Mbp, and over 5,000 genes. Expression of these numerous genes is controlled by a 
complex network of transcriptional and post-transcriptional regulatory mechanisms (34). 
Several of these regulatory mechanisms are discussed later. 
 
1.5.1 Quorum Sensing 
P. aeruginosa uses three overlapping quorum sensing (QS) systems to regulate gene 
expression. QS facilitates coordinated gene expression in response to environmental 
signals and bacterial population density. Thus, QS is used to coordinate population-wide 
gene expression for pathogenesis, metabolism, and many other processes (35). Two of 
these systems, Las and Rhl, produce acylhomoserine lactone (AHL) autoinducers, while 
the third involves the quinolone molecule PQS (35). QS controls expression of type II 
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secretion (T2SS), elastase, pyocyanin, and pyoverdine in P. aeruginosa, among other 
factors (35). 
 
1.5.2 Two-Component Systems 
There are about 130 genes involved with two-component systems (TCSs) in P. aeruginosa 
(36). TCS are commonly found also in other species belonging to this genus. These 
regulatory systems mediate a variety of functions for the microbes (Table 1.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7 
 
Table 1.1: Some Important Two-Component Systems in P. aeruginosa and Their 
Functions (1) 
 
Sensor Histidine Kinase Response Regulator Function 
PilS PilR Pilus gene expression 
NtrB NtrC Nitrogen metabolism 
PhoR PhoB Phosphate assimilation 
FleS FleR Motility and adhesion properties 
GacS GacA Pathogenesis 
PfeS PfeR Iron Uptake 
 
 
1.5.3 Sigma Factors 
A large number of sigma factors have been reported in Pseudomonas species, and these 
sigma factors are critical for optimal RNA polymerase-mediated gene transcription activity. 
Some important ones are described below. 
 
1.5.3.1 σ70 
This sigma factor is important for housekeeping gene transcription (37). The consensus 
sequence found in σ70-dependent promoters in P. aeruginosa has similarity to that found 
in Escherichia coli. 
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1.5.3.2 Extracytoplasmic Function Sigma Factors 
This subgroup of σ70 family factors is important for control of extracytoplasmic stress (38). 
An important extracytoplasmic function (ECF) sigma factor is AlgU, which regulates 
biosynthesis of the secreted polysaccharide alginate (39). It is also considered to regulate 
heat shock sigma factor σ32, and hence is implicated to be a global gene regulator (40). 
Another ECF sigma factor, PvdS, regulates pyoverdine siderophore biosynthesis. A 
sequence at the −35 position, known as the “IS box,” is critical for PvdS-dependent 
promoter functioning (41). Interestingly, orthologues of the P. aeruginosa PvdS have been 
reported in P. putida (strain KT2440) and P. fluorescens (42). 
 
1.5.3.3 σ54 
This sigma factor is encoded by rpoN and is distinct from the σ70 family. Some of the major 
functions of RpoN include regulation of glutamine synthetase and urease in P. aeruginosa, 
as well as some virulence factors. The number and function of σ54-dependent genes varies 
greatly among various Pseudomonas species (43, 44). For example, it is involved in the 
regulation of the phytotoxin coronatine in P. syringae. 
 
1.5.4 Other Transcriptional Regulators 
There are quite a few families of transcriptional regulators found in P. aeruginosa, 
including members of the AsnC, GntR, LacI, LuxR, and MarR families (1). For catabolism 
of aromatic hydrocarbons, various species use σ54-dependent regulator families such as 
XylR, TouR, and DmpR (45).  
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1.5.5 Post-Transcriptional Regulation 
Post-transcription regulation has also been reported in P. aeruginosa. For example, the 
TCS GacAS and the membrane bound proteins RetS and LadS regulate transcription of 
two small noncoding regulatory RNAs: RsmY and RsmZ (3) (Fig. 1.1). These RNAs 
control the intracellular concentration of free RsmA, a prominent member of the CsrA 
family of RNA-binding proteins. RsmA controls translation of certain transcripts by 
binding to conserved 5′-ANGGAN-3′ motifs present within stem-loop secondary structures 
of target mRNAs, such as those for type III secretion system (T3SS) genes. Such binding 
sites often overlap or are proximal to the ribosome binding site of these target mRNAs (46, 
47), and thus RsmA binding blocks ribosome recognition and translation initiation. RsmA 
also post-transcriptionally stimulates gene expression through effects on mRNA stability 
and secondary structure (48, 49). RsmY and RsmZ each have 4–6 RsmA binding sites. 
Thus, presence of these regulatory RNAs controls the free concentration of RsmA and its 
ability to bind target mRNAs (3). Post-transcriptional regulation is reported in other 
Pseudomonas species as well. As an example, in P. fluorescens, the hcnABC operon 
(involved in expression of hydrogen cyanide synthase expression) is under control of the 
small noncoding RNAs RsmA and RsmE (50, 51). 
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Figure 1.1. Post transcriptional regulation by small RNAs RsmY and RsmZ. 
The inner membrane (IM) associated sensor kinase GacS, phosphorylates and activates its 
cognate response regulator GacA, which directly binds to and activates transcription of 
regulatory small RNAs RsmY and RsmZ. Increased rsmY/rsmZ levels, in turn, sequester 
RsmA, preventing it from enhancing translation of exsA, thus inhibiting T3SS. RetS forms 
a heterodimer with GacS and prevents it from activating GacA, while LadS activates GacA 
phosphorylation by an unknown mechanism (see text for details).  
 
1.6 Pathogenesis of P. aeruginosa 
P. aeruginosa causes infection in a wide range of different host organisms, including 
humans. The importance of P. aeruginosa as an opportunistic pathogen stems from three 
major concerns: high incidence of infection, high morbidity and mortality, and 
recalcitrance to immune or antibiotic clearance (52). P. aeruginosa is the leading 
pathogen causing acute respiratory infections in mechanically ventilated and 
immunocompromised individuals and chronic infections in the airways of individuals 
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with cystic fibrosis (CF) (53, 54). P. aeruginosa has also been implicated in other 
opportunistic diseases such as those of the urinary tract, eye, skin, and burn wounds (55). 
 
1.6.1 General Pathogenicity Attributes 
During infection, P. aeruginosa is thought to be acquired from the environment, 
including, importantly, the hospital. Bacterial cell surface virulence factors, such as 
flagella, pili, and lipopolysaccharide (LPS), aid in initial adhesion to the host epithelial 
layer (52). This is often followed by injection of effector molecules (ExoU, ExoS, ExoT, 
ExoY) into the host epithelium through the T3SS. These effectors facilitate host cell 
cytoskeleton rearrangement, escape from host cell phagocytic engulfment, and 
cytotoxicity leading to tissue necrosis (55). Other secreted virulence factors involved in 
host cell cytotoxicity and tissue destruction include elastase, phospholipase C, and 
pigments such as pyoverdine and pyocyanin (56, 57). Production of this arsenal of 
virulence factors is tightly regulated by an intricate network of QS, TCSs, stress response 
systems, and other factors (55, 58, 59). 
 
1.6.1.1 Cell Surface Virulence Factors 
As the name suggests, these factors are localized on the cell surface. They mediate 
bacterial motility and the early stages of infection, such as initial adhesion to the host cell 
surface. 
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 Flagella 
In addition to providing motility for P. aeruginosa, flagella bind to asialoGM1, a normal 
constituent of the host epithelial cell membrane (60). They are also known to prompt an 
NFκB mediated inflammatory reaction, such as production of interleukin IL-8, by 
interacting with TLR2 and TLR5 (61). Because flagella are immunogenic, they often are 
downregulated during infection, especially in chronic infections like those in the CF 
airways (see below). Immunogenicity of flagellar proteins has been exploited by 
researchers to develop immunological products targeted towards them (62). 
 
 Pili  
Pili are also critical for P. aeruginosa virulence (63), particularly for adherence to the 
host cell surface by binding to asialoGM1 (64, 65). They are also involved in twitching 
motility, which is dependent upon retractile movement of the pili. This activity leads to 
spreading, rather than swimming, of the bacterial population on the host tissue surface. 
This kind of locomotion is especially prevalent in respiratory tract infections (66). 
Because of the importance of pili for virulence, immunological targeting of pili is a major 
area of research (67-69). 
 
 LPS  
LPS is crucial in P. aeruginosa pathogenesis (69). LPS assists P. aeruginosa in binding 
to asialoGM1 (65) and elicits pro-inflammatory cascades through interaction of lipid A 
with TLR4/CD14 (70). 
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1.6.1.2 Type III Secretion System 
T3SS is a complex molecular syringe that is used by P. aeruginosa to inject four effector 
toxins (ExoU, ExoS, ExoT, and ExoY) into the host cell cytosol. Intriguingly, it has been 
reported that mutants that lack effectors, but still express the T3SS structure are still 
virulent (71), indicating that the T3SS needle complex by itself might be important in P. 
aeruginosa pathogenesis. PcrV is an important structural protein making up the tip of the 
T3SS needle (72), and immunotherapeutics targeted at PcrV have achieved some success 
(73). 
 
 ExoU  
ExoU is the most potent of the P. aeruginosa T3SS effectors (71, 74) and it is the 
predominant cytotoxin injected by the T3SS (74, 75). It destroys host cell membranes 
through its phospholipase/lysophospholipase activities (76, 77). Anti-ExoU 
immunotherapy has been generally unsatisfactory (52), but some success has been 
achieved with phospholipase A2 inhibitors in vitro (78). As the mechanism of ExoU 
activity becomes clearer, newer therapeutic strategies will emerge. 
 
 ExoS  
The ExoS cytotoxin (71) disrupts the host cell cytoskeleton through two different 
activities (52). The C-terminus, which requires a 14–3–3 cofactor protein, contains ADP-
ribosyltransferase activity (74, 79) and the N-terminal domain acts as a Rho GTPase 
activating protein (GAP). ExoS provokes inflammatory responses through TLR2 and 
TLR4 (80). 
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 ExoT  
ExoT is regarded a minor effector (74). This toxin contains domains similar to ExoS, 
although the ADP-ribosyltransferase domain in ExoT affects a more restricted subset of 
host cellular proteins, including Crk (81). ExoT induces cytoskeletal rearrangements, 
leading to inhibition of P. aeruginosa internalization and stunted wound healing (82). 
Some studies have reported that ExoT production decreases ExoU-mediated cell 
cytotoxicity (71). 
 
 ExoY  
ExoY functions as an adenylate cyclase (55), and upon being injected into the host cell 
cytoplasm, increases intracellular cAMP levels (83). Increased host intracellular cAMP 
leads to increased tissue porosity, especially in lung infections (84). 
 
1.6.1.3 Other Secreted Virulence Elements 
P. aeruginosa secretes a number of other factors that contribute to disease progression. 
These factors, such as secreted pigments, enzymes, and proteases, destroy host tissues, 
increase tissue porosity, and induce host inflammatory reaction, among other functions 
(Table 1.2) (52).  
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Table 1.2: Secreted Virulence Factors in Pseudomonas aeruginosa and Their Functions 
(1) 
Factor Description/Function 
Pyocyanin Blue pigment; induces IL-8 expression and apoptosis of neutrophils; 
causes oxidative damage in 
host cells 
Pyoverdine Siderophore for iron chelation and uptake; virulence regulator 
controlling secretion of exotoxin A 
and itself 
Alkaline 
protease 
Cleaves fibrin in host tissue; prevalent in corneal infections and in 
lung disease 
Protease IV Important in keratitis caused by P. aeruginosa; also implicated in 
airway infections due to 
destruction of lung surfactant proteins A, B, and D 
Elastase Metalloproteinase secreted into the extracellular space; 
destroys tight junctions leading to porosity of airway epithelial 
tissue; induces inflammation by 
recruiting neutrophils and eliciting IL-8 response; also reported to 
disrupt lung surfactant proteins 
A and D 
Phospholipase 
C 
Secreted into the extracellular space; disrupts host cell membrane 
phospholipids, 
especially in acute lung disease; participates in surfactant 
destruction, inflammation induction, and 
inhibition of neutrophil oxidative burst 
Exotoxin A Functions as an ADP-ribosyltransferase that blocks elongation factor 
2, leading to impaired protein synthesis and host cell death 
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1.6.1.4 Biofilm formation 
By definition, ‘biofilms’ are ‘matrix enclosed bacterial populations adherent to each other 
and/or to surfaces or interfaces’ (85). Thus, a surface attached bacterial sedentary biofilm 
lifestyle is markedly different from a ‘planktonic’ or free-swimming one. There are four 
distinct stages of biofilm formation in P. aeruginosa. The first stage involves initial 
attachment to a biotic (eg. host epithelium) or abiotic surface. The second phase is 
characterized by microcolony formation, wherein microbes cluster with each other and 
the sedentary surface. In stage three, the microcolonies progress in size and complexity to 
develop into the mature three-dimensional biofilm structure, with water channels and an 
exopolysaccharide matrix. This is followed by the final stage, biofilm dispersion, wherein 
some bacteria detach from the biofilm, switch to a planktonic mode of growth and leave, 
either to remain planktonic or to form a biofilm elsewhere (also known as ‘biofilm 
cycling’). Changes in gene expression occur at each stage as the bacteria transit from the 
planktonic phase and slowly adapt to the biofilm lifestyle. 
 
Though biofilms are ubiquitously found in various natural environments (86), in the 
clinical setting, biofilm formation is severely problematic as it renders survival advantage 
to the pathogen. Typically, biofilms are associated with higher recalcitrance to clearance 
by the host immune system and to antimicrobial therapy (87). There are three main 
mechanisms to account for this. One, the biofilm matrix (composed mainly of 
exopolysaccharides and extracellular DNA and protein) provides a mechanical barrier to 
host immune system based cells and chemicals and other foreign antimicrobials such as 
antibiotics from reaching the bacterial population. Secondly, due to altered gene 
regulation in biofilm-associated bacteria, stress response genes become transcriptionally 
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activated, further resulting in high antibiotic resistance. Additionally, oxygen and nutrient 
deprivation in the center of the biofilm render the bacteria non-growing and thus 
impervious to antibiotics. 
 
P. aeruginosa biofilms generally display lower expression of acute virulence factors like 
the T3SS and diminished cytotoxicity, but importantly, increased production of factors, 
like exopolysaccharide, that enhance persistence (88). Indeed, P. aeruginosa biofilms are 
widely implicated in chronic infections like that in a diabetic foot wound, on prosthetic 
devices and, as a prototype example, in the airways of CF patients.   
   
1.6.2 P. aeruginosa Pathogenesis in the CF Lung Environment 
CF is a congenital genetic disease, marked by improper chloride secretion across cell 
membranes (89). Particularly in the airway epithelium, this defect leads to unusually 
excessive amounts of mucus building up (89), which provides an excellent niche for 
microbes to proliferate. Though there are multiple pathogens that colonize the CF lung, P. 
aeruginosa predominates from adolescence though adulthood (90). 
 
P. aeruginosa causes a persistent, lifelong infection in the airways of individuals with CF 
(90). These chronic infections initiate as P. aeruginosa adjusts to the CF airway 
environment and transitions to a biofilm lifestyle (91). As mentioned previously, this 
biofilm infection in CF lungs is strikingly dissimilar to acute P. aeruginosa infections. 
T3SS and expression of toxins like elastase are diminished. Virulence features that trigger 
host immunity, like flagella and pili, are downregulated once the pathogen has established 
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adherent contact with the host respiratory epithelium. On the other hand, biofilm bacteria 
produce vast amounts of the exopolysaccharide alginate, leading to a highly mucoid 
phenotype (92). 
 
P. aeruginosa biofilms in the context of CF airways hold serious clinical implications (93). 
Firstly, CF biofilms are nearly impossible to eradicate due to elevated antibiotic resistance 
(94). Secondly, despite intense host immune infiltration, bacteria are protected from 
destruction within the biofilm. Moreover, inflammation leads to damage of surrounding 
host tissues (92). Thus, P. aeruginosa persists for the life of the individual, and it is 
recognized as the leading cause of morbidity and mortality in CF patients (95). Thus, 
understanding the molecular cascades that enable P. aeruginosa to form biofilms has been 
the focus of much research. 
 
1.7 Relevant background studies 
Because the P. aeruginosa biofilm lifestyle is associated with much poorer clinical 
outcomes (96), it is pivotal to elucidate the genes and biochemical pathways that help the 
bacteria either 1) switch to the biofilm form from the acute (high T3SS) lifestyle, or 2) 
maintain the biofilm lifestyle. The key to the identification of such genes, is to investigate 
the pathogen in conditions which best simulate those where P. aeruginosa indeed forms 
antibiotic resistant biofilms (like that in the CF airway environment). 
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1.7.1 A co-culture biofilm system to simulate the CF lung environment 
A major hindrance to studying microbial pathogenesis in the CF lung is the lack of suitable 
animal models possessing the CF phenotype and sustaining chronic microbial infection (97, 
98). To overcome this, a novel tissue culture based model system was developed (87, 91), 
wherein P. aeruginosa forms biofilms directly on an immortalized human CFBE cell 
monolayer in culture. Such a co-culture model is more physiologically relevant than 
biofilms grown on abiotic surfaces such as plastic, because of their distinctive response to 
stimuli like antibiotics (91). In other words, this model, to a considerable extent, simulates 
the actual P. aeruginosa pathogenesis going on in the CF airway environment.  
 
1.7.2 MgtE modulates virulence in P. aeruginosa 
Using the co-culture model described above, it has been shown that the P. aeruginosa inner 
membrane magnesium transporter MgtE is a virulence modulator (91). Specifically, 
biofilm formed by a ΔmgtE isogenic deletion strain exhibits higher cytotoxic effects 
towards cultured airway cells compared to the wild type P. aeruginosa strain. Furthermore, 
complementation of the mutant with a plasmid expressing mgtE results in restoration of 
the wild type phenotype. Genetic analyses revealed that mgtE inhibits cytotoxicity in P. 
aeruginosa by decreasing transcription the T3SS. Additionally, mgtE was found to inhibit 
T3SS expression also in liquid (non-biofilm, free swimming lifestyle) culture (99). Because 
cytotoxicity inhibition is a prominent feature of the biofilm lifestyle, these results suggest 
that MgtE might be a key signaling molecule facilitating the transition of the bacteria 
between the acute and chronic phases of growth. Intriguingly, MgtE’s toxin modulating 
function appear to be separate from its transport functions (99).  
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1.7.3 MgtE is a putative antibiotic-stress response regulator 
Recent studies showed that the antibiotic tobramycin, which is extensively used clinically 
to treat P. aeruginosa airway infection in CF patients (100), enhanced MgtE transcription 
in co-culture biofilms (91). It was additionally found that multiple antibiotics (9 out of 12 
tested) induced mgtE expression in P. aeruginosa (2). This indicates that MgtE responds 
to antibiotic stress, possibly in connection with its role as a virulence modulator. Since the 
CF lung environment challenges P. aeruginosa with a wide range of stresses, including 
antibiotic stress, MgtE might be an important molecule necessary for P. aeruginosa 
growing predominantly in its biofilm lifestyle to survive in the CF lung.  
 
1.7.4 AlgR inhibits MgtE’s activity 
AlgR is pleiotropic response regulator in P. aeruginosa, known to affect T3SS transcription 
(101) as well as production of the biofilm exopolysaccharide alginate (102), among other 
things. Through a genetic screen of putative virulence modulators, mutation of algR 
disrupted mgtE’s activity (2). Specifically, a ΔmgtE/ΔalgR double isogenic mutant led to 
decreased toxicity (Fig.1.2), instead of the expected toxicity increase.  
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Figure 1.2. AlgR disrupts the cytotoxicity phenotype of mgtE.  
The ∆mgtE and algR::Tn strains both display increased cytotoxicity, compared to WT, 
when grown as biofilms on cultured CFBE cells. However, mutation of both in the same 
strain leads to decreased cytotoxicity. Figure courtesy Carly V. Redelman (2). 
1.8 Vital Questions 
These previous studies have provided valuable insight into a novel mechanism by which 
P. aeruginosa regulates virulence during biofilm formation in chronic infections. However, 
these studies failed to elucidate the exact molecular mechanism by which mgtE affected 
T3SS. Furthermore, it was unclear how MgtE and AlgR cooperated to alter toxicity. 
Addressing these vital questions will provide novel understanding of how P. aeruginosa 
responds to environmental cues to appropriately regulate transitions between planktonic 
and biofilm lifestyles. 
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1.9 Study Aims 
The overall goal of my research is to discern the molecular mechanisms of mgtE-mediated 
regulation of cytotoxicity in P. aeruginosa. This was accomplished by elucidating the 
pathway through which mgtE inhibits the T3SS, as well as investigating the molecular basis 
of the genetic interaction between algR and mgtE, whereby these two genes crosstalk to 
exert effects on the T3SS. Though the role of mgtE in T3SS regulation in P. aeruginosa 
was first discovered using P. aeruginosa biofilms growing in vitro on CFBE cells (91), in 
this study, the mechanistic characterization of mgtE’s effect on the T3SS has been done 
using planktonic cultures of P. aeruginosa instead of biofilm models of the bacteria. This 
is because of two reasons: 1) mgtE mediated regulation of T3SS gene expression is 
conserved between both the biofilm and the planktonic modes of growth in P. aeruginosa 
(99) and 2) ease of experimentation using planktonic P. aeruginosa cultures as opposed to 
its biofilms. The studies done shed more light on the virulence regulatory networks in P. 
aeruginosa, and bacterial pathogenesis in general, which going forward, would help in the 
development of novel therapeutic targets against P. aeruginosa.   
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 SOLUBILIZATION AND SELECTIVE 
PROTEOMIC ANALYSIS OF MGTE IN PSEUDOMONAS 
AERUGINOSA 
2.1 Introduction 
As described in Chapter 1, the T3SS is a molecular syringe-like apparatus that is employed 
by Pseudomonas aeruginosa to inject toxins into host cells to facilitate cytotoxicity. 40 
gene products, which include proteins that form the injectisome, chaperones and effector 
toxins, constitute the T3SS in P. aeruginosa. The proteins which control the central or 
‘intrinsic’ regulation of the T3SS are also among these 40 genes. The whole of the T3SS 
regulon (i.e. these 40 proteins) is transcribed from 10 operons, and it is dependent upon 
free levels of the master T3SS transcription factor ExsA, which regulates its own 
transcription as well (55). Under conditions of low or no T3SS, another protein, ExsD, 
sequesters ExsA and prevents it from binding to its target promoters. Under these 
conditions, 2 other regulatory proteins ExsE and ExsC remain bound to each other. Under 
conditions that upregulate the T3SS in P. aeruginosa (such as host cell contact, serum, or 
low Ca2+), ExsE is transported out of the cell, thus liberating ExsC. This free ExsC then 
binds to and sequesters ExsD away from ExsA, hence increasing free levels of ExsA in the 
cell. ExsA in turn, binds to all the T3SS promoters (including the operon from which it is 
transcribed) and turns on T3SS gene expression (55) (Fig. 2.1). The proteins ExsE, ExsC, 
ExsD and ExsA constitute the ‘intrinsic’ regulatory machinery of the P. aeruginosa T3SS. 
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Figure 2.1. Schematic representation of the ‘intrinsic’ regulation of the P. aeruginosa 
T3SS and autoregulation of ExsA. See text for details. 
 
Previous studies have shown that MgtE, an inner membrane magnesium transporter (99), 
inhibits ExsA-driven T3SS gene transcription in P. aeruginosa (91, 99). Further, mgtE was 
found to bypass the intrinsic regulatory steps governed by exsE, exsC and exsD and act at 
the level of exsA, but the exact mechanism was unknown. Considering the protein/protein 
interactions involved in the intrinsic regulatory cascade, we hypothesized that MgtE might 
also be sequestering ExsA directly (like ExsD), thus preventing it from facilitating T3SS 
gene transcription. In this chapter, I describe my exploration of this hypothesis.   
2.2 Materials and Methods 
Bacterial strains, plasmids and culture conditions. The bacterial strains used in this 
study are wild type (WT) P. aeruginosa strain PA14 and isogenic deletion mutants in mgtE 
(∆mgtE) and exsA (∆exsA). All of these strains have been reported earlier (99). Strains were 
transformed with plasmid pmgtE (PA14 mgtE with N-terminal 6x histidine tag cloned into 
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vector pMQ72) (99) or its empty backbone vector pMQ72 (103) by electroporation. 
Plasmids were maintained in Escherichia coli S17 (99) cultured on LB agar plates or LB 
containing 10 µg/mL gentamicin. Transformed P. aeruginosa was cultured in LB agar 
plates with 60 µg/ml gentamicin, and the presence of the respective plasmids was 
confirmed by performing PCR with primers p729 (5’ CAGACCGCTTCTGCGTTCTG 3’) 
and p730 (5’ GCAACTCTCTACTGTTTCTCC 3’) (2). For biochemical analysis, 
overnight cultures of respective strains with the respective plasmids were subcultured 
(1:1000 dilution) in LB containing 60 µg/ml gentamicin and 2mM EGTA (2) and grown 
to OD600=1.0. 
 
Preparation of whole cell lysate and Western blotting. Whole cell lysates were prepared 
as previously described (3). Briefly, 1.25 ml of cells from the respective cultures (grown 
to OD600=1.0) were pelleted by centrifugation at 10,000 rpm. The pellet was thereafter 
washed with PBS (phosphate buffered saline), resuspended in 250 µl SDS-PAGE sample 
buffer, sonicated for 10s and finally boiled at 950C for 5mins. The whole cell proteome 
samples from different strains were analyzed by SDS-PAGE, followed by Western blotting 
using either anti-ExsA (3) antibody (1:1000) (kind gift from Dr. Timothy L. Yahr, 
University of Iowa) or anti-Histidine antibody (1:1500) (Qiagen) as the primary antibody. 
Appropriate fluorescent tagged (Alexa Fluor 690 or 780, Thermofisher or Jackson 
Immunologicals) secondary antibodies (1:10000) (donkey anti-rabbit and donkey anti-
mouse for anti-ExsA and anti-His primary antibodies respectively) were utilized and 
fluorescence was measured by Image Studio (LI-COR Biosciences, Lincoln, NE) as 
described previously (104). 
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Cell lysis, solubilization of inner membrane proteins, protein purification, Western 
blotting and mass spectroscopic analysis. P. aeruginosa cultures were grown to an 
optical density of OD600=1.0. For crosslinking of proteins, formaldehyde was added to the 
respective cultures at 0.6% final concentration and incubated for 20mins at 370C, as 
described previously for crosslinking inner membrane and cytosolic proteins in Gram-
negative bacteria (105). This was followed by harvesting of cells by centrifugation at 
10,000 rpm and washing them with Tris-HCl buffer (20mM Tris-HCl, 0.5M Sucrose, pH 
8.0). Subsequently, spheroplasts were prepared by incubating the harvested cells in 
lysozyme (2mg/ ml in 0.1M EDTA, pH 7.5) for 30mins at 40C. Spheroplasts thus obtained 
were harvested by centrifugation at 2700xg for 30mins, resuspended in a lysis buffer 
composed of 20mM Tris-HCl, pH 8.0 containing the protease inhibitor PMSF at 0.1mM 
concentration and lysed by either 4 1min pulses of sonication (105, 106) (30% power, 
alternating 10s on and off) on ice, by using a French pressure cell (107) (courtesy 
department of Biochemistry, IUSM), or by bead beating (107) (courtesy Dr. Richard 
Gregory). Unlysed cells and cellular debris were eliminated by centrifugation for 10mins 
at 10,000xg in a microcentrifuge. To separate cytosolic proteins from those in the inner 
membrane, ultracentrifugation (100,000xg) (Beckman, rotor type 70Ti) was performed for 
30mins. To solubilize proteins from the inner membrane, the pellet containing the 
membrane fraction from the previous step was resuspended in the lysis buffers containing 
different concentrations (1%, 2%, 3%, 4%) of the detergent sodium dodecyl maltoside 
(SDDM) (105) followed by stirring for 1hr at 40C. Since 2% SDDM was the most effective 
in solubilizing MgtE out of the inner membrane (see Results), this concentration was used 
in subsequent experiments. Following solubilization, the insoluble fraction was separated 
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from the solubilized membrane proteins by ultracentrifugation (100,000xg) for 30mins, as 
above. Solubilized MgtE (containing 6x histidine tag) was purified as described previously 
(104, 105) with a few modifications. The solubilized membrane fraction was treated with 
anti-His antibody at a final concentration of 5µg/ml and incubated for 1hr at 40C with 
constant stirring. Magnetic Protein G beads were then added to the samples followed by 
rotation for 2hrs at 40C. The beads were then magnetically separated and washed thrice 
with the lysis buffer containing 0.05% SDDM. SDS-PAGE sample buffer (SDS 20g/L, 
Tris-base 9.7g/L, b-mercaptoethanol 7.5mL/L, glycerol 100mL/L, bromophenol blue 
100mG/L, pH 6.8) was added to the beads thus obtained, followed by heating for 10mins 
at 700C, protein separation by SDS-PAGE and subsequent mass spectroscopic analysis or 
Western blotting for ExsA or MgtE-6xHis (as described above). For mass spectroscopy, 
the immunoprecipitates resolved by SDS-PAGE were stained with Imperial Stain (104) 
(ThermoFisher). Several acrylamide gel regions were excised (courtesy Dr. Michael Edler, 
Baucum lab, IUPUI), and mass spectroscopy was performed as described previously (104) 
by Dr. Lisa Jones (Department of Chemical Biology, IUPUI) and analyzed using the 
annotated genome of P. aeruginosa strain PA14 (courtesy Dr. AJ Baucum). 
2.3 Results and Discussion 
Standardization of the anti-His and anti-ExsA Western blots. Various blocking buffer 
compositions, incubation times, primary and secondary antibody conditions were tested to 
standardize the anti-His (Fig 2.2A) and anti-ExsA (Fig 2.2B) immunoblots in our 
laboratory. The best blocking appeared to be in 5% non-fat dry milk in buffer composed 
of 150 mM NaCl, 50 mM Tris-HCl pH 7.5 and 0.5% (v/v) Triton X-100 with overnight 
incubation at 40C. The ideal treatments for the anti-His and anti-ExsA Western blots 
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seemed to be 1:1500 and 1:1000 primary antibody dilutions in blocking buffer (150 mM 
NaCl, 50 mM Tris-HCl pH 7.5, 0.5% (v/v) Triton X-100, 5% non-fat dry milk), 
respectively.  
 
Figure 2.2. Anti-MgtE-6xHis (A) and anti-ExsA (B) immunoblots.  
As described in the Materials and Methods, anti-His primary antibody was used to identify 
MgtE-6xHis (55kDa) (A) and anti-ExsA primary antibody was used to detect ExsA (31.6 
kDa) (B). Donkey anti-mouse and donkey anti-rabbit secondary antibodies were used in 
(A) and (B) respectively. 
 
MgtE expression does not lead to localization of ExsA to the inner membrane. Despite 
being an inner membrane protein in P. aeruginosa (99), MgtE has been reported to have 
cytosolic domains (108). Thus, we hypothesized that MgtE, by its cytoplasmic domains, 
directly binds to and sequesters ExsA, thereby preventing it from binding to its target 
promoters and activating T3SS gene transcription. To test this hypothesis, we lysed the 
cells, separated the membrane fraction from the cytosolic proteins and performed anti-
ExsA immunoblot on the membrane lysate to see if ExsA co-localized to the inner 
membrane under elevated levels of mgtE expression (from a plasmid), keeping a ∆mgtE 
mutant as the negative control. As evident, ExsA did not localize to the membrane fraction 
even high MgtE expression (Fig. 2.3). 
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Figure 2.3. Anti-ExsA immunoblot to test for membrane localization of ExsA under mgtE 
overexpression.  
∆mgtE strain with empty vector (Vector) and wild type (WT) strains with either vector or 
pmgtE (mgtE-6xHis cloned into vector) were cultured, membrane fractions were separated 
from cytosolic proteins (see Materials and Methods), resuspended in SDS- PAGE sample 
buffer and immunoblotted for ExsA. Whole cell lysates from the WT and ∆exsA strains 
were used as positive and negative controls respectively.  
 
A major caveat in this experiment is the absence of crosslinking. Also, there is a 
possibility that MgtE does not tether ExsA directly, but indirectly affects ExsA by 
binding to some other protein.  
 
Standardization of the detergent concentration for MgtE solubilization out of the 
inner membrane. We wanted to quantitatively identify any protein(s) that potentially co-
immunoprecipitated with MgtE. Thus, we first solubilized MgtE out of the inner membrane 
using 4 different concentrations of the detergent Sodium Dodecyl Maltoside (SDDM). As 
shown in Figure 2.4, solubilization using 2% SDDM yielded the best results. 
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Figure 2.4. Standardization of MgtE solubilization from the inner membrane.  
MgtE-6xHis was solubilized out of the inner membrane using 4 different concentrations of 
the detergent SDDM and the solubilized MgtE-6xHis in the supernatant was quantitatively 
detected using anti-His Western blot. 
 
We then purified MgtE from membrane preparations using an anti-His antibody (as 
described in the Materials and Methods) and Protein A beads, unconjugated it from the 
beads by heating, and analyzed the samples by SDS-PAGE to see if any protein(s) co-
precipitated with MgtE, keeping the ∆mgtE mutant strain as negative control. As seen from 
Figure 2.5, there are multiple bands that we found in the lanes corresponding to the 
immunoprecipitated (with MgtE-6xHis) lysate under high expression of MgtE (pmgtE) 
with either formalin crosslinking and non-crosslinking, as compared to that in the ∆mgtE 
mutant. We cut these bands out and analyzed by mass spectroscopy. This analysis indicated 
that these bands were truncated forms of MgtE. There were a few other proteins that were 
identified in our study, but the corresponding spectral counts were negligible as compared 
to those for MgtE. 
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Figure 2.5. SDS-PAGE analysis for selective proteomics of MgtE.  
∆mgtE strain with pmgtE (mgtE-6xHis cloned into vector) was cultured, membrane 
fractions were separated from cytosolic proteins (see Materials and Methods), solubilized 
using 2% SDDM and MgtE-6xHis was purified using Protein A beads and the respective 
immunoprecipitates were analyzed by SDS-PAGE using Imperial stain. –CL and +CL 
indicates absence and presence of crosslinking by formalin. The 55kDa MgtE protein and 
the bands excised and sent for mass spectroscopic analysis are highlighted in boxes. The 
∆mgtE strain with empty vector (Vector) was used as the negative control. 
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These results suggest that MgtE does not directly bind to ExsA. We recognize two caveats. 
First, the protein-protein interactions we were looking for might be transient and thus could 
have been cleaved during the process of MgtE solubilization and purification. Though we 
used formalin crosslinking, it might not be the most appropriate reagent for our purpose. 
Second, we analyzed only the prominent bands in the immunoprecipitated eluate, rather 
than the whole eluate. Thus, proteins that were immunoprecipitated in very low amounts, 
such that they did not show up as prominent bands on the SDS-PAGE, were not analyzed 
at all. However, considering the low likelihood of finding a binding interaction, versus the 
efforts required to optimize additional co-immunoprecipitation experiments, we decided to 
take a more genetic approach to uncover the mechanisms behind MgtE-mediated regulation 
of T3SS, as detailed in Chapters 3 and 4.   
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 THE PSEUDOMONAS AERUGINOSA 
MAGNESIUM TRANSPORTER MGTE INHIBITS TYPE III 
SECRETION SYSTEM GENE EXPRESSION BY STIMULATING 
RSMYZ TRANSCRIPTION 
3.1 Introduction 
The Gram-negative bacterium Pseudomonas aeruginosa is implicated in a wide range of 
opportunistic infections in humans (109, 110). A major virulence factor used by P. 
aeruginosa to initiate acute infections is a type III secretion system (T3SS) (81, 111). This 
macromolecular apparatus spans the bacterial cell envelope and acts like a syringe, 
injecting several toxins directly into host cells (112). This leads to actin cytoskeleton 
rearrangement, host cell rounding, and cell death (112, 113). These actions promote tissue 
damage and decrease phagocytic clearance (71, 88, 114). In addition to acute infections, P. 
aeruginosa is also able to establish chronic infections through biofilms formation, most 
notably in the airways of cystic fibrosis (CF) patients (88, 115). During P. aeruginosa 
biofilm formation, altered gene regulation typically leads to a reduction in T3SS gene 
expression (88, 116-119). Additionally, isolates from chronically colonized CF patients 
usually contain mutations that decrease T3SS production (88, 120). Thus, during both acute 
and chronic infections, P. aeruginosa appears to tightly regulate T3SS gene expression in 
response to environmental conditions. 
 
P. aeruginosa T3SS gene expression is controlled by the master transcription factor ExsA, 
which is responsible for activating transcription of all T3SS genes, including exsA itself by 
autoregulation (55). Under non-inducing conditions, ExsA is bound by the anti-activator 
protein ExsD and is unable to bind to its target promoters to initiate gene transcription. 
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Two other proteins important for T3SS regulation, ExsC and ExsE, form a separate 
complex. Under inducing conditions (contact of P. aeruginosa with host cells, the presence 
of serum, or low Ca2+ conditions), ExsE is secreted through the T3SS apparatus, thus 
permitting ExsC to sequester ExsD. ExsA, released from ExsD, subsequently activates the 
T3SS regulon. This mechanism has been referred to as ‘intrinsic regulation’ (55) (Fig. 2.1). 
 
In addition to the ExsDCE network, several other pathways also control exsA expression 
and/or synthesis (55, 88). These pathways work concurrently but distinctly from ‘intrinsic 
regulation’ to further control T3SS gene expression and are referred to as ‘extrinsic 
regulation’. One example of extrinsic regulation is the RsmA/RsmY/RsmZ signaling 
cascade (Fig. 1.1). RsmA is an RNA binding protein belonging to the CsrA family (121). 
CsrA family members regulate gene expression at the post-transcriptional level by binding 
to target mRNAs at conserved sequence motifs and impacting their stability and/or 
translation (121). RsmA appears to control T3SS gene expression by increasing exsA 
translation through an undetermined mechanism (3). This activity depends upon the 
concentration of free RsmA in the cell and is controlled by two non-coding RNAs, RsmY 
and RsmZ (3, 122). RsmY and RsmZ function by directly sequestering RsmA from target 
mRNA (3, 123-125) and are thus negative regulators of ExsA synthesis. Transcription of 
rsmYZ is directly controlled by the GacAS two-component system (TCS) (3, 121, 126, 
127). The environmental signals governing RsmY and RsmZ expression are poorly 
understood but include two additional sensor kinases, LadS and RetS. Both GacS and LadS 
are able to phosphorylate the GacA response regulator to enhance rsmY and rsmZ 
transcription (128, 129). In contrast, RetS inhibits GacA-mediated rsmY and rsmZ 
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transcription by forming a heterodimer with GacS and preventing GacA phosphorylation 
(130).  
 
Previous studies found that the P. aeruginosa inner membrane magnesium transporter 
MgtE inhibits T3SS gene expression (99). Whereas an mgtE mutant demonstrates 
enhanced T3SS gene expression, mgtE overexpression inhibits the T3SS (99). The 
mechanism by which mgtE inhibits the T3SS was not elucidated in these prior studies, 
although the effect of MgtE on T3SS gene expression is distinct from its role as a Mg2+ 
transporter in P. aeruginosa (99). In the current study, we show that mgtE expression 
inhibits ExsA translation by increasing rsmY and rsmZ transcription. We also demonstrate 
that mgtE acts exclusively through the RsmA/RsmY/RsmZ signaling pathway to inhibit 
ExsA-mediated T3SS gene transcription. Because mgtE transcription is significantly 
upregulated by growth under low Mg2+ conditions and in the presence of some antibiotics 
(2, 106), this pathway may provide a mechanism for P. aeruginosa to modulate T3SS gene 
expression in response to signals encountered during infections. 
3.2 Materials and Methods 
Bacterial strains and culture conditions. The bacterial strains used in this study are listed 
in Table 3.1. Plasmids were maintained in Escherichia coli S17 (99) cultured on LB agar 
plates or LB containing 10 µg/mL gentamicin. Plasmids were isolated from E. coli using 
QIAprep Spin Miniprep kit (Qiagen) according to the manufacturer’s instructions and 
electroporated into appropriate P. aeruginosa strains. Transformed P. aeruginosa was 
cultured in Vogel Bonner Minimal (VBM) medium (3, 131) agar plates with 60 µg/ml 
gentamicin, and the presence of the respective plasmids was confirmed by performing PCR 
36 
 
with primers p729 (5’ CAGACCGCTTCTGCGTTCTG 3’) and p730 (5’ 
GCAACTCTCTACTGTTTCTCC 3’) (2). For beta-galactosidase assays, P. aeruginosa 
strains were cultured overnight on VBM agar plates with gentamicin. Cells were sub-
cultured the next day to a starting concentration of OD600=0.1 in Trypticase Soy Broth 
(TSB) supplemented with 100 mM monosodium glutamate and 1% glycerol (3). 2 mM 
EGTA was added to the media to induce T3SS gene expression (132, 133). 
Table 3.1. Bacterial strains used in this study. 
Bacterial Strains Relevant Characteristics References 
PA103 PexsD-lacZ WT strain, with the ExsA-dependent PexsD-
lacZ reporter chromosomally integrated at 
the CTX site 
(3, 81, 115, 
134) 
UY241 Constitutive transcription of exsCEBA in 
PA103 PexsD-lacZ background 
(135) 
PA103 PlacUV5-
exsCEBA’-’lacZ 
PlacUV5-driven exsA translational reporter 
integrated at the CTX site 
(3) 
PA103 PlacUV5-
exsCEB’-’lacZ 
PlacUV5-driven exsB translational reporter 
integrated at the CTX site 
(3) 
PA103 PlacUV5-
exsCE’-’lacZ 
PlacUV5-driven exsE translational reporter 
integrated at the CTX site 
(3) 
PA103 PlacUV5-
exsC’-’lacZ 
PlacUV5-driven exsC translational reporter 
integrated at the CTX site 
(3) 
PA103 CVS 
Reporter 
PlacP1-lacZ reporter for cAMP-Vfr Signaling (136) 
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Table 3.1 continued 
PA103 PexsD-lacZ                
∆vfr 
Isogenic deletion of vfr in PA103 PexsD-lacZ 
background 
(3) 
PA103 PexsD-lacZ 
∆algZR 
Isogenic deletions of algZ and algR in PA103 
PexsD-lacZ background 
(3) 
PA103 PexsD-lacZ 
∆rsmYZ 
Isogenic deletions of rsmY and rsmZ in 
PA103 PexsD-lacZ background 
(3) 
PA103 PrsmY-lacZ rsmY transcriptional reporter chromosomally 
integrated at the CTX site 
(3) 
PA103 PrsmZ-lacZ rsmZ transcriptional reporter chromosomally 
integrated at the CTX site 
(3) 
PA103 PrsmA-lacZ 
 
PA103 PrsmY-lacZ 
∆gacA 
 PA103 PrsmY-lacZ 
∆gacS 
PA103 PrsmZ-lacZ 
∆gacA 
PA103 PrsmZ-lacZ 
∆gacS 
rsmA transcriptional reporter chromosomally 
integrated at the CTX site 
Isogenic deletion of gacA in PA103 PrsmY-
lacZ background 
Isogenic deletion of gacS in PA103 PrsmY-lacZ 
background 
Isogenic deletion of gacA in PA103 PrsmZ-
lacZ background 
Isogenic deletion of gacS in PA103 PrsmZ-lacZ 
background 
(3, 137) 
 
(3) 
 
(3) 
 
(3) 
 
          (3) 
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Beta-galactosidase assays. P. aeruginosa was grown to OD600=1.0 and beta-galactosidase 
activity was measured as reported earlier (3). Ortho-nitrophenyl-β-D-galactopyranoside 
(ONPG) was used as the substrate for beta-galactosidase in all the beta-galactosidase 
assays involving transcriptional reporters; chlorophenol red–β-d-galactopyranoside 
(CPRG) was used as the substrate in assays involving translational reporters (3, 138). 
Plasmid pmgtE (99), and its empty backbone vector pMQ72 (103), were used to assess the 
effect of mgtE expression on transcription and translation. 
 
RNA isolation and quantitative real time PCR (qRT-PCR). P. aeruginosa strains were 
cultured as above for beta-galactosidase assays and harvested at OD600=1.0, whereupon the 
pellet was washed with phosphate buffered saline (PBS). This was followed by RNA 
isolation using the RNeasy Plus kit (Qiagen) according to the manufacturer’s instructions. 
A few modifications were made to the protocol, as described earlier (2). Briefly, the RNA 
was subjected to on-column DNase digestion prior to elution. Additionally, after elution, a 
second DNase digestion was performed, followed by the RNA Cleanup procedure. These 
digestions result in negligible DNA contamination of the final isolated RNA sample (2). 
cDNA was synthesized from the RNA using the Superscript III First-Strand Synthesis 
System for RT-PCR (Invitrogen), according to the manufacturer’s guidelines (2). DNA 
contamination of the RNA preparations was tested in control reactions by performing 
cDNA synthesis in the absence of reverse transcriptase. Quantitative Real Time PCR (qRT-
PCR) was performed as previously reported (2) using primers lacZRTfor (5’ 
CAACTGTTTACCTTGTGGAG 3’) and lacZRTrev (5’ TATGAACGGTCTGGTCTTTG 
3’), which bind to a central region in the exsA-lacZ transcript. Samples were normalized to 
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the fbp transcript using primers PA5110for (5’ CCTACCTGTTGGTCTTCGACCCG 3’) 
and PA5110rev (5’ GCTGATGTTGTCGTGGGTGAGG 3’) (2, 91, 99, 139). 
 
Statistical analyses. At least three independent experiments were performed for each assay. 
Two-sample Student’s T test was used to determine statistical significance (p<0.05). 
3.3 Results 
MgtE inhibits T3SS gene expression at the post-transcriptional level. Previous studies 
found that mgtE expression inhibits T3SS gene transcription (99). We considered three 
possibilities to account for the inhibitory effect of mgtE expression: 1) reduced exsA 
transcription, 2) reduced ExsA synthesis, and/or 3) impaired ExsA function. Because exsA 
regulates its own transcription (by acting at the PexsC promoter to control transcription of 
the exsCEBA operon) (140), it was necessary to uncouple exsA transcription from its own 
control to analyze potential mgtE effects on exsA transcription. To this end, we used the 
previously described P. aeruginosa UY241 strain (135), in which the ExsA-dependent 
PexsC promoter has been replaced with a constitutive variant of the PlacUV5 promoter (Pcon). 
As a control, PexsD-lacZ reporter activity (as a marker for ExsA-dependent transcription) 
was measured in wild type (WT) PA103 and the UY241 strain following growth under 
non-inducing (high calcium, –EGTA) and inducing (low calcium, +EGTA) conditions for 
T3SS gene expression (133, 141, 142). Whereas ExsA is sequestered by ExsD in the WT 
strain under non-inducing conditions and PexsD-lacZ reporter activity is low, EGTA 
stimulation results in the release of ExsA from ExsD and induction of PexsD-lacZ reporter 
activity (Fig. 3.1A) (143). Strain UY241 also demonstrates EGTA-dependent induction of 
PexsD-lacZ reporter activity, but the overall level of activity is reduced due to the lack of 
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ExsA autoregulation at the PexsC promoter (Fig. 3.1A). We next expressed mgtE in the WT 
(Fig. 3.1B) and UY241 strains (Fig. 3.1C) and measured PexsD-lacZ reporter activity. In 
both the WT and UY241 strains, mgtE expression resulted in a significant reduction in 
PexsD-lacZ reporter activity. These data suggest that MgtE inhibits T3SS gene expression 
at a post-transcriptional level. 
 
Figure 3.1. mgtE inhibits T3SS gene expression at the post-transcriptional level. 
(A) PA103 PexsD-lacZ (WT) and UY241 were assayed either under T3SS non-inducing (–
EGTA) or inducing (+EGTA) conditions and assayed for beta-galactosidase activity from 
the PexsD-lacZ reporter construct. Percent activity was calculated considering the PexsD-lacZ 
activity in EGTA-treated WT as 100%. *p<0.0005, n.s.=not significant. (B) PA103 PexsD-
lacZ (WT) with either vector control or pmgtE was assayed under T3SS inducing 
conditions and beta-galactosidase activity from the PexsD-lacZ construct was measured. 
Percent activity was calculated considering the PexsD-lacZ activity in WT with blank vector 
as 100%. **p<0.05. (C) Strain UY241 with either vector control or pmgtE was assayed 
under T3SS inducing conditions and beta-galactosidase activity from the PexsD-lacZ 
construct was measured. Percent activity was calculated considering the PexsD-lacZ activity 
in UY241 with blank vector as 100%. ***p<0.005. 
 
ExsA translation is repressed by mgtE expression. We next tested the hypothesis that 
mgtE expression inhibits ExsA translation. We introduced the mgtE expression vector 
(pmgtE) into a panel of WT PA103 strains carrying lacZ translational reporters fused to 
exsC, exsE, exsB, or exsA (fused in-frame with lacZ at codons 15, 15, 2, and 77, 
respectively) (3). Each reporter is integrated in single copy on the chromosome at the CTX 
phage attachment site and transcribed from a constitutive PlacUV5 promoter. Whereas 
plasmid-expressed mgtE reduced exsCEBA’-‘lacZ translational reporter activity by almost 
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3-fold (Fig. 3.2A), mgtE had no negative impact on the exsC’-‘lacZ (Fig. 3.2B), exsCE’-
‘lacZ (Fig. 3.2C), or exsCEB’-‘lacZ reporter activities (Fig. 3.2D). These data suggest that 
mgtE expression inhibits ExsA translation and that this activity is specific to exsA in the 
exsCEBA operon. For reasons that are unclear, the exsCEB’-‘lacZ reporter showed a 
significant increase upon mgtE expression. 
 
Figure 3.2. mgtE expression specifically represses exsA translation.  
Translational reporter strains of (A) exsA (exsCEBA’-’lacZ), (B) exsC (exsC’-’lacZ), (C) 
exsE (exsCE’-’lacZ), and (D) exsB (exsCEB’-’lacZ), with either vector control or pmgtE 
were assayed under T3SS inducing (+EGTA) conditions for beta-galactosidase activity. 
Percent activity was calculated considering the lacZ activity from the respective strains 
with the blank vector as 100%. The reporter constructs were transcribed from a constitutive 
PlacUV5 promoter. *p<0.005, **p<0.05, n.s.=not significant. 
 
The small intergenic region between exsB and exsA contains a Vfr-dependent promoter 
(PexsA) (144). Because the PexsA promoter is present in the exsCEBA’-‘lacZ translational 
reporter, we considered the possibility that mgtE inhibits PexsA promoter activity, thus 
accounting for the observed reduction in exsCEBA’-‘lacZ activity. To investigate this 
hypothesis, we monitored the effect of mgtE expression on a cAMP-Vfr signaling (CVS) 
reporter (136). The CVS reporter consists of lacZ fused to the cAMP- and CRP/Vfr-
dependent lacP1 promoter from E. coli. As shown in Fig. 3.3A, mgtE expression had no 
significant effect on CVS reporter activity. This result is further supported by the finding 
that mgtE expression in a vfr mutant still inhibits PexsD-lacZ activity (Fig. 3.3B). We infer 
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from these data that mgtE does not alter transcription from the PexsA proximal promoter by 
acting through vfr.    
 
Figure 3.3. The CVS cascade is not required for mgtE-mediated inhibition. 
(A) mgtE expression does not repress CVS reporter activity. PA103 CVS reporter strains 
with either vector control (Vector) or pmgtE were assayed for beta-galactosidase activity 
from the CVS reporter under T3SS inducing conditions (+EGTA). n.s.=not significant. (B) 
mgtE inhibits T3SS gene transcription in a ∆vfr background. ∆vfr strains with either vector 
control (Vector) or pmgtE were cultured under T3SS inducing (+EGTA) conditions and 
assayed for beta-galactosidase activity from the PexsD-lacZ reporter construct. Percent 
activity was calculated considering the PexsD-lacZ activity in the ∆vfr strain with blank 
vector as 100%. *p<0.005.  
 
It is also possible that mgtE inhibits steady state levels of exsA mRNA rather than 
specifically inhibiting exsA translation. To distinguish between these two possibilities, we 
isolated mRNA from strains carrying the exsCEBA’-‘lacZ translational reporter with either 
a vector control or pmgtE and performed quantitative real time PCR (qRT-PCR) using 
primer pairs designed for a region central to the exsA-lacZ transcript. Intriguingly, mgtE 
expression increased exsA-lacZ transcript levels (Fig. 3.4). This finding suggests that mgtE 
might have positive effects on exsA mRNA steady state levels, but more importantly, it 
strongly suggests that the post-transcriptional inhibition on ExsA synthesis by mgtE is due 
to repression of ExsA translation as opposed to impaired exsA mRNA levels. 
43 
 
 
Figure 3.4. exsA mRNA remains stable upon mgtE expression.  
mRNA was isolated from the exsA’-’lacZ translational reporter strain containing either the 
vector control or pmgtE, and exsA transcript stability was analyzed by qRT-PCR. lacZ 
transcript abundance was normalized to that of the control transcript of fbp. *p<0.05. 
 
mgtE upregulates rsmY and rsmZ transcription in a GacAS dependent manner.  We 
next examined possible mechanisms for the mgtE-mediated exsA inhibition. We reasoned 
that since mgtE is an inner membrane protein (99), its translation repressive effects on exsA 
were likely indirect, possibly by stimulating one of the established signaling pathways that 
control ExsA translation. For this reason, we investigated whether mgtE affected 
RsmA/RsmY/RsmZ signaling (3). To explore this hypothesis, we measured PrsmY-lacZ, 
PrsmZ-lacZ, and PrsmA-lacZ transcriptional reporter activity (3) and found that mgtE 
expression significantly upregulates rsmY and rsmZ transcription by approximately 2.5-
fold and 2-fold, respectively (Fig 3.5A-B). Interestingly, mgtE expression also stimulated 
rsmA transcription (Fig. 3.5C), but to a smaller degree than measured for rsmY and rsmZ.  
Because the GacAS two-component system is essential for rsmY and rsmZ transcription 
(17, 18, 23, 24), we hypothesized that the mgtE effect requires GacAS. As evident from 
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Fig. 3.5A-B, mgtE expression failed to stimulate PrsmY-lacZ and PrsmZ-lacZ reporter 
activities in the absence of either gacA or gacS, thus supporting a role for GacAS in mgtE-
mediated rsmYZ regulation.   
 
Figure 3.5. mgtE expression affects rsm signaling by a GacAS-dependent mechanism. 
Transcriptional reporter strains of (A) rsmY (PrsmY-lacZ), (B) rsmZ (PrsmZ-lacZ), and (C) 
rsmA (PrsmA-lacZ), in WT, ∆gacA, and ∆gacS backgrounds with either vector control or 
pmgtE were assayed under T3SS inducing (+EGTA) conditions for beta-galactosidase 
activity. Percent activity was calculated considering the lacZ activity from the respective 
WT reporter strains with the blank vector as 100%. *p<0.005, **p<0.05. 
 
mgtE expression in an rsmY/rsmZ mutant fails to inhibit T3SS gene expression. Since 
our data suggest that mgtE affects RsmA/RsmY/RsmZ signaling to inhibit exsA translation, 
we next tested whether the effect of MgtE functions solely through RsmA/RsmY/RsmZ 
signaling to inhibit ExsA-dependent transcription by expressing mgtE in an rsmY/rsmZ 
double mutant. Consistent with a previous report (55), the rsmY/rsmZ mutant demonstrates 
increased PexsD-lacZ reporter activity when compared to WT (Fig. 3.6). Whereas mgtE 
expression significantly inhibited PexsD-lacZ reporter activity in the WT background, 
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reporter activity was unaffected in the rsmY/rsmZ mutant (Fig. 3.6). These data suggest 
that mgtE works solely through the RsmA/RsmY/RsmZ signaling cascade to inhibit exsA 
translation. 
 
Figure 3.6. RsmYZ are required for MgtE-mediated inhibition of T3SS gene 
transcription.  
PA103 PexsD-lacZ and ∆rsmYZ PexsD-lacZ strains with either vector control or pmgtE were 
assayed under T3SS inducing (+EGTA) conditions for beta-galactosidase activity from the 
PexsD-lacZ reporter construct. Percent activity was calculated considering the PexsD-lacZ 
activity in WT with blank vector as 100%. *p<0.0005, **p<0.005, n.s.=not significant.  
3.4 Discussion 
The central role of ExsA as the primary regulator of P. aeruginosa T3SS makes it an 
attractive target for therapeutic development (55). Defining signaling networks that control 
exsA expression, synthesis, and activity is critical to realizing that goal. Previous work 
found that the MgtE magnesium transporter inhibits T3SS gene expression (99). In this 
study, we demonstrate that MgtE accomplishes this activity by inhibiting exsA translation 
(Fig. 3.7). 
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Figure 3.7. A model for mgtE-mediated translational repression of exsA.  
MgtE affects signaling through GacAS, through an unknown mechanism, to stimulate 
transcription of rsmY and rsmZ. Increased rsmY/rsmZ levels, in turn, sequester RsmA, 
preventing it from enhancing translation of exsA, thus inhibiting T3SS. 
 
MgtE-mediated inhibition of exsA translation appears to occur through the 
RsmA/RsmY/RsmZ pathway (Figs. 3.5-3.6). Increased RsmY and RsmZ levels sequester 
RsmA, resulting in decreased exsA translation. Importantly, we found that mgtE expression 
does not decrease exsA transcript levels (Fig 3.4), further supporting the conclusion of a 
specific effect on translation. Additionally, lack of involvement of Vfr in MgtE-mediated 
T3SS gene transcription inhibition strongly indicates that exsA translation inhibition is not 
the result of decreased transcription activity from the PexsA promoter located on translational 
fusion constructs (Fig. 3.3). The fact that MgtE does not inhibit other genes in the exsCEBA 
operon (Fig. 3.2) suggests that there may be regulatory sequences specific to exsA 
translational control. 
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Overexpression of mgtE also enhances rsmA transcription (Fig. 3.5C), although to a much 
lesser degree than rsmY and rsmZ (Fig. 3.5A and B). As was proposed in another study, it 
is plausible that the net result from increased rsmA, rsmY, and rsmZ transcription is reduced 
RsmA availability (3). First, RsmA positively regulates rsmY and rsmZ transcription, 
which likely plays a role in maintaining homeostasis (3, 145). Second, RsmA binds to its 
own mRNA to repress translation (146). Therefore, the mgtE-dependent increase in rsmA, 
rsmY, and rsmZ expression could result in reduced RsmA availability and decreased exsA 
translation (see Fig. 3.2).  
 
MgtE lacks helix-turn-helix or other DNA binding motifs (108, 147), which would be 
needed to directly impact transcription. Therefore, it seems that the positive effect of MgtE 
on rsmY and rsmZ transcription is indirect. This is indeed supported by our data that mgtE 
expression fails to affect rsmY and rsmZ transcription in both a gacA and a gacS mutant 
(Fig. 3.5A-B). These results also establish that MgtE influences rsmY and rsmZ 
transcription through GacAS. As a membrane protein, MgtE could be involved in direct or 
indirect binding interactions with GacS, LadS, RetS, or a novel membrane protein that 
affects signaling through GacS. Because MgtE signals through GacA and GacS, it would 
be interesting to investigate whether MgtE expression leads to higher phosphorylated states 
of GacA. It is important to note that RetS was found to regulate biofilm formation in 
response to magnesium limitation (148), a condition that also enhances mgtE transcription 
(106). Future work will investigate the mechanism by which mgtE affects GacAS signaling. 
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It is noteworthy that mgtE transcription is significantly upregulated in low Mg2+ and high 
antibiotic conditions (2, 106), commonly found during host infections like the CF lung 
environment (149-155). We expressed mgtE from a plasmid to simulate the effects of high 
mgtE expression, such as could occur during host infection. Thus, our study describes a 
mechanism that might allow P. aeruginosa to respond to the host environment and 
optimize T3SS gene expression. Additionally, because MgtE signals through GacAS, our 
results indicate two environmental signals encountered by P. aeruginosa during infection 
(low Mg2+ and high antibiotics during infection) that potentially affect the GacAS signaling 
pathway. Thus, it is possible that MgtE serves as a sensor, altering T3SS expression in 
response to changes in the extracellular environment (i.e. magnesium levels and 
antibiotics). Because the effect on exsA levels and T3SS gene expression are modest (Figs. 
3.1-3.2, 3.6) (99), we suggest that MgtE “fine-tunes” the T3SS response in accordance with 
the chemical environment, rather than acting as a binary on/off switch.    
 
MgtE is important for the pathogenesis of other microorganisms, such as Aeromonas 
hydrophila and Campylobacter jejuni (156, 157). A. hydrophila, in particular, has both a 
T3SS and an RsmA homologue (158, 159). An intriguing avenue of future research will be 
to investigate whether MgtE homologs in other pathogens inhibit T3SS through a 
conserved mechanism of action (i.e. modulation of RsmA activity). Similar to MgtE in P. 
aeruginosa, the housekeeping Mg2+ transporter CorA, found in numerous bacteria, is 
reported to transport Mg2+ and modulate virulence as two distinct functions (160). Future 
work will investigate whether CorA signaling is similar to that of P. aeruginosa MgtE. 
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Taken together, our current study describes the mechanism by which MgtE inhibits T3SS 
gene transcription in P. aeruginosa. This signaling cascade is one mechanism used by P. 
aeruginosa to respond to Mg2+ scarcity and high antibiotic conditions. Additional 
characterization of upstream events of this signaling cascade (i.e. how MgtE affects 
GacAS signal transduction) would further increase our understanding of the mechanism 
used by P. aeruginosa to orchestrate signaling pathways in response to the host 
environment. 
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 MGTE AND ALGR GENETICALLY INTERACT TO 
AFFECT THE T3SS IN PSEUDOMONAS AERUGINOSA 
This chapter in part, has been published in reference (2). Required permission has been 
obtained. 
4.1 Introduction 
Pseudomonas aeruginosa possesses an intricate network of signaling pathways to regulate 
cytotoxicity. Typically, cytotoxicity is downregulated in chronic P. aeruginosa infections, 
wherein they form antibiotic resistant biofilms, as in the CF airways (3). The gold standard 
antibiotic used to treat P. aeruginosa biofilm infections in the CF lungs is tobramycin (161), 
which still fails to completely eradicate the pathogen, because of inherent antibiotic 
resistance mechanisms and robust transcription of stress response genes (162). In a 
previous study, to identify the genes in P. aeruginosa biofilms which are upregulated upon 
tobramycin treatment, a co-culture of P. aeruginosa biofilms growing on CFBE cells was 
treated with physiologically relevant levels of tobramycin, followed by microarray analysis 
(91). One of the major genes in P. aeruginosa that was found to be transcriptionally 
upregulated was the inner membrane Mg2+ transporter gene mgtE. Additionally, as 
mentioned in Chapters 2 and 3, mgtE was found to inhibit cytotoxicity in P. aeruginosa. A 
follow up study by our lab revealed that, in P. aeruginosa biofilms, several other antibiotics 
(in addition to tobramycin) enhance mgtE transcription (2). This indicates that mgtE might 
be involved in stress response pathways in P. aeruginosa.  
 
A transposon mutagenesis screen, to elucidate the pathways through which mgtE might be 
signaling, revealed that the P. aeruginosa gene algR abrogated mgtE mediated inhibition 
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of cytotoxicity (Fig 1.1) (2). This indicates a genetic crosstalk between algR and mgtE. 
AlgR has pleiotropic effects in P. aeruginosa (163). It is a response regulator involved in 
production of the biofilm polysaccharide alginate by binding to the algD promoter and 
activating transcription (164).  AlgR also activates various stress response cascades. 
Importantly, algR is responsive to several antibiotics, including tobramycin (91), imipenem 
(165) and numerous cell wall-active antibiotics (166). Additionally, it inhibits cytotoxicity 
in P. aeruginosa by at least two different mechanisms (3). 
 
In this current study, I have shown that mgtE may react particularly to antibiotics, among 
stress conditions. Also, in spite of enhanced transcription under antibiotic pressure, mgtE 
does not confer antibiotic resistance to P. aeruginosa. Further, I have attempted to 
characterize the genetic crosstalk between mgtE and algR in P. aeruginosa. Specifically, I 
have established that a ΔmgtE/ΔalgR double mutant inhibits cytotoxicity in P. aeruginosa 
(Fig 1.1) due to inhibition of T3SS gene transcription. My data also reveals that the algR-
mgtE genetic interaction is specifically targeted towards regulation of the T3SS in P. 
aeruginosa, rather than indiscriminately affecting other virulence phenotypes. To further 
elucidate the interaction between mgtE and algR, I demonstrate that algR inhibits mgtE 
transcription, but not vice versa. Taken together, this study sheds more light on the 
complicated signaling networks that govern biofilm formation, cytotoxicity and stress 
tolerance in P. aeruginosa. 
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4.2 Materials and Methods 
Strains and plasmids. Bacterial strains and plasmids used in this study are listed in Table 
4.1. Primers used in this study are listed in Table 4.2. 
 
 
 
Table 4.1. Strains and plasmids used in this study 
 
Strain or 
plasmid 
Relevant genotype or description Reference or 
source 
PA14 WT P. aeruginosa burn wound isolate (167) 
SMC3604  
PA14 ∆mgtE 
(91) 
GGA225 PA14 ∆algR This study 
GGA226 PA14 : : PmgtE–lacZ  This study 
 
GGA231 PA14 ∆mgtE ∆algR This study 
 
SC100 PA14 : : PalgR–lacZ This study 
SC101 SMC3604 : : PalgR–lacZ  This study 
 
SC102 GGA225 : : PmgtE–lacZ This study 
 
SMC4405 PA14 : : PexsD–lacZ (91) 
SMC4406 SMC3604 : : PexsD–lacZ (91) 
PA14 PexsA-
lacZ 
PA14 WT having PexsA-lacZ reporter 
chromosomally integrated at the CTX site  
This study 
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Table 4.1 continued 
PA14 PexsA-lacZ ∆mgtE 
∆algR 
Isogenic deletion of mgtE and algR in PA14 
PexsA-lacZ background 
This study 
S17-1 Escherichia coli laboratory strain for cloning (91) 
Saccharomyces 
cerevisiae 
 
InvSc1: In vivo cloning; ura3-52/ura3-52  Invitrogen 
 
pMQ30 Allelic replacement vector, yeast cloning (168) 
pMQ70 PBAD expression vector; Cb (168) 
pMQ72 PBAD expression vector; Gm (168) 
pSMC233 mgtE deletion; pMQ30 backbone; Gm (91) 
pSMC233-Amp mgtE deletion; pMQ30 backbone; Amp This study 
pSMC291 mgtE complementation; pMQ70 backbone (91) 
pSC1 algR deletion; pMQ30 backbone; Gm This study 
pMQ30-lacZ Promoterless lacZ in pMQ30; Gm This study 
pGA233  pMQ30-PmgtE–lacZ; Gm This study 
pSC2 pMQ30-PalgR–lacZ; Gm This study 
 
Table 4.2. Primers used in this study 
Primer Sequence (5’– 3’) 
913for CCCATGGACTTACCCAGTAG 
913rev CCGTCGACGAGTATTTCGTC 
p729 CAGACCGCTTCTGCGTTCTG 
p730 GCAACTCTCTACTGTTTCTCC 
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Table 4.2 continued 
30AMPfor TAAGATCCTTGAGAGTTTTCGCCCCGAAGAACGTTTTCCAATG
A TGAGCACTTTTAAAGT 
30AMPrev AATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTA
C CAATGCTTAATCAGTG 
AlgRKO#1 TCGACTGAGCCTTTCGTTTTATTTGATGCCTGGCAGTTCCCTGG 
ACCTGTCCGACCTGTT 
AlgRKO#2 CATGCAGGAAGCCTGAGCTTCACTCGGGTTCGAACTGTTA 
AlgRKO#3 GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTGT
A GGTGTTCGAGACGAAAG 
AlgRKO#4 TAACAGTTCGAACCCGAGTGAAGCTCAGGCTTCCTGCATG 
AlgRKOU
P 
CTTATCTATGGCATCCAGCC 
AlgRKOD
OWN 
CTTGACGAACAGGCCCTTGC 
LacZfor GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTAA
GATCCAAATGACCATGATTACGGATTC 
LacZrev AGGCAAATTCTGTTTTATCAGACCGCTTCTGCGTTCTGATTTAT
T TTTGACACCAGACCA 
MgtEProm
LacZfor 
GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGCTGC
C TTTTTCGTCTTCGTCTC 
MgtEProm
LacZrev 
GTTGTAAAACGACGGCCAGTGAATCCGTAATCATGGTCATAG
C GCGCTCCACCCCCAGTA 
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Table 4.2 continued 
AlgRPromFor GGAATTGTGAGCGGATAACAATTTCACACAGGAAACAGC
TTGT TCATGTGCACGTCTTCC 
AlgRPromLacR
ev 
GTTGTAAAACGACGGCCAGTGAATCCGTAATCATGGTCA
TCGA CAGAGTTTCCGCAAGGC 
 
 
Genetic manipulations. Construction of isogenic deletion mutants. Isogenic deletion 
mutants were created as described previously elsewhere (91, 168). For deleting the algR 
gene, algR flanking regions were amplified by PCR with primer pairs 
AlgRKO#1/AlgRKO#2 and AlgRKO#3/AlgRKO#4, and the resultant PCR fragments 
were joined to suicide vector pMQ30 via homologous recombination in Saccharomyces 
cerevisiae (168). This deletion vector, pSC1, was then electroporated into Escherichia coli 
S17-1 cells and plasmid construction was confirmed by restriction digestion. The deletion 
vector harbored by S17-1 transformants was transferred by conjugation into target P. 
aeruginosa strains. Exconjugants were isolated on selective agar plates (either 50 mg 
gentamicin/ ml and 30 mg nalidixic acid/ ml or 250 mg carbenicillin/ ml and 30 mg 
nalidixic acid/ ml). Following the selection, the exconjugants were grown overnight in LB, 
and spontaneous excision of the vector was selected for by plating on 10% sucrose/LB 
plates. Mutations were confirmed by PCR, using primer pair AlgRKOUP/AlgRKODOWN, 
and sequencing. For deletion of mgtE, we started with the plasmid pSMC233, which has a 
gentamicin selective cassette (91). However, because the transposon mutants that we used 
already have gentamicin resistance, we generated pSMC233-AMP, which is pSMC233 
with a carbenicillin gene cassette replacing the gentamicin cassette. This was accomplished 
by PCR-amplifying the bla gene from pMQ70 using primer pair 30AMPfor/30AMPrev. 
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The resultant PCR fragment was mixed with BglII-digested pSMC233, and, using the S. 
cerevisiae homologous recombination technique (168), the bla gene replaced the aacC1 
gene on pSMC233, thus creating pSMC233-AMP. Deletions of mgtE were confirmed via 
PCR using the primers 913for and 913rev. 
 
Transcriptional fusions with lacZ. The PexsD–lacZ reporter constructs were reported earlier 
(141). We created algR and mgtE isogenic deletions in strains carrying the PexsD–lacZ 
construct (99) as described above. To create strains with PalgR–lacZ and PmgtE–lacZ 
transcriptional fusions, we first generated plasmid pMQ30-lacZ, which carries a 
promoterless lacZ gene on plasmid pMQ30, which is a suicide vector in P. aeruginosa. 
This was accomplished by amplifying the lacZ gene from E. coli S17-1 using primers 
LacZfor and LacZrev. This PCR fragment was recombined with BamHI-digested pMQ30 
via homologous recombination in S. cerevisiae, as above. Next, the putative promoter 
regions of mgtE and algR were PCR amplified using primers MgtEPromLacZfor and 
MgtEPromLacZrev, or AlgRPromFor and AlgRPromLacRev. These PCR fragments were 
recombined with BamHI-digested pMQ30-lacZ via homologous recombination in S. 
cerevisiae, creating plasmids pGA233 (PmgtE–lacZ) and pSC2 (PalgR–lacZ). These plasmids 
were then electroporated into E. coli S17-1 cells and plasmid constructs were confirmed 
via restriction digestion. Plasmids were transferred to P. aeruginosa strains by conjugation, 
and exconjugants were identified via selective agar plates (LB with 50 mg gentamicin/ ml 
and 30 mg nalidixic acid/ ml). These exconjugants contained a single crossover insertion 
of the plasmid at the mgtE or algR native sites (strains GGA226 and SC100 in the PA14 
background, and strains SC102 and SC101 in the ΔalgR or ΔmgtE backgrounds, 
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respectively), which positioned the promoterless lacZ gene immediately downstream of the 
mgtE or algR promoters. The pMQ30 plasmid contains strong transcriptional terminators 
downstream of the lacZ gene (168). 
 
Complementation of strains. The plasmid pSMC291 contains full length mgtE, and it has 
been previously described (99). 
 
Beta-Galactosidase assays. The Miller assay was carried out as we have previously 
performed (99) with a few modifications. Overnight cultures of bacterial strains were 
subcultured 1:100 into LB with 2 mM EGTA (to chelate calcium for enhancing T3SS 
stimulation), and these subcultures were grown until mid-exponential phase (OD600~0.5). 
Subsequently, the cultures were diluted in appropriate volumes of Z buffer [16.1 g 
Na2HPO4. 7H2O/ l, 5.5 g NaH2PO4.4H2O/ l, 0.75 g KCl/ l, 0.246 g MgSO4.7H2O/ l, 2.7 ml 
beta-mercaptoethanol (pH 7.0)], and then 40 ml chloroform and 10 ml 0.1% SDS were 
added to each of the aliquots. This solution was vortexed for 10 s and incubated at 300C 
for 5 min. A total of 200 ml (4 mg/ml) ONPG was added for 30 min at 300C, and then 0.5 
ml 1 M Na2CO3 was added to stop the reaction. Expression of lacZ was determined by the 
standard Miller unit equation (Miller Units=1000*(OD600/ (time in mins*volume of 
culture*OD600)) wherein the data were normalized to the OD600 value of the bacterial 
culture, as we have previously calculated (99). Chlorophenol red–β-d-galactopyranoside 
(CPRG) was used as the substrate in assays involving the PexsA-lacZ transcriptional reporter 
(144). Data are representative of three independent experiments. For the beta-galactosidase 
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assay of the PmgtE–lacZ and PalgR–lacZ strains, the same procedure as above was followed, 
except that EGTA was omitted. 
 
For testing of stresses on the PmgtE–lacZ construct, we subcultured WT P. aeruginosa from 
overnight cultures into 1.5 ml fresh LB in 24-well plates. Plates were incubated for 12 h, 
statically, and then bacteria were subjected to the indicated stresses for 30 min. The  M63 
salts consisted of 15 g KH2PO4/ l, 35 g K2HPO4/ l, 10 g (NH4)2SO4/ l in water. Beta-
galactosidase assays from co-culture biofilms were performed as previously described (99). 
 
Twitching motility. Twitching-motility assays were performed by dipping a pipette tip 
into overnight cultures of the indicated bacterial strain and then stabbing the tip to the 
bottom of an LB agar plate, as described elsewhere (169). Plates were incubated at 370C 
for 24 h, then for an additional 24 h at room temperature. Then, the agar was removed, and 
the plate was stained with 0.1% crystal violet for 10 min. Twitching zone sizes were 
determined by measuring three diameters for each zone and averaging. Each strain was 
tested in three independent experiments with three to six replicates each. 
 
Rhamnolipid production. To detect rhamnolipids, we prepared M8 medium 
supplemented with 1 mM MgSO4, 0.2% glucose, 0.5% casamino acids, 0.2% 
cetyltrimethylammonium bromide (CTAB), 0.0005% methylene blue, and 1.5% agar, as 
described elsewhere (170). Overnight culture of each strain (5 ml) was spotted on the 
surface of the agar and the plates were incubated at 370C for 24 h, then for an additional 
24 h at room temperature. Secreted rhamnolipid is precipitated by the CTAB and thus 
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forms a halo around each colony, with the diameter related to the amount of rhamnolipid 
produced. Diameters were measured as above for twitching. Each strain was tested in three 
independent experiments with three to six replicates each. 
 
Pyocyanin production. Pyocyanin production was assessed by chloroform extraction of 
filter-sterilized overnight culture supernatants, as previously described (91). OD376 was 
measured in a SpectraMax M2 spectrophotometer as a measure of relative pyocyanin levels. 
Each strain was tested in three independent experiments with three to four replicates each. 
 
AlgR biochemical studies. AlgRD54E, a phosphomimetic form of AlgR (164) was used 
to test whether AlgR directly binds to the mgtE promoter in vitro. Expression and 
purification of AlgRD54E was previously described (164). For the electrophoretic mobility 
shift assay (EMSA), the previously described protocol was used (164). For the assay, 6 
different concentrations of purified AlgRD54E were used (0.15 µM, 0.3 µM, 0.6 µM, 1.25 
µM, 5 µM and 10µM). The test oligonucleotide encompassed the mgtE promoter region 
containing the putative AlgR binding site (shown in bold: 5’-
CAGTTTCCCGTTTGACCAATCAC-3’). The algD promoter was used as positive 
control (5’-TGGCGCTACCGTTCGTCCCTCCGA-3’, AlgR binding site shown in bold. 
These experiments were performed by Dr. Michael Schurr, University of Colorado. 
 
Statistical analysis. Statistical significance was determined via a P value <0.05 using a 
two-tailed Student’s t-test with Sidak adjustment for multiple comparisons. 
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4.3 Results 
MICs are unaffected by changes in magnesium concentration. It is possible that 
increased expression of mgtE could affect antibiotic resistance. Because MgtE is a 
magnesium transporter, and because magnesium limitation increases mgtEexpression 
(171), we wondered whether incubation in decreased magnesium levels resulted in greater 
antibiotic resistance. We assayed the MIC of tobramycin, gentamicin, ciprofloxacin and 
imipenem, as representatives of the three modes of action of the antibiotics that were tested 
previously (2) (protein synthesis inhibition, replication inhibition, cell wall inhibition). We 
found that the MIC remained the same (Table 4.3), despite growth in magnesium 
concentrations that stimulate (0.1 mM) or repress (1 mM) mgtE transcription (171). 
Combined with our previous observation that antibiotic sensitivity was unaffected by 
isogenic deletion of mgtE (91), it seems that mgtE expression exerts only a minor role, if 
any, on antibiotic resistance. The antibiotic-resistance phenotype is likely multifactorial. 
Table 4.3. Minimum Inhibitory Concentrations of P. aeruginosa in Different Magnesium 
Levels 
 Tobramycin Gentamicin Ciprofloxacin Imipenem 
1 mM Mg2+ 3 4 0.5 1.5 
0.1 mM Mg2 3 4 0.5 1.5 
0.01 mM Mg2 3 4 0.5 1.5 
 
Effect of various stresses other than antibiotics on mgtE transcription. Since mgtE 
transcription was upregulated in antibiotic treated P. aeruginosa biofilms, we tested 
whether mgtE transcription upregulation was part of a general stress response pathway in 
P. aeruginosa, or whether the response was largely restricted to antibiotic pressure. To 
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this end, we constructed an mgtE transcriptional reporter in P. aeruginosa by fusing a 
lacZ gene downstream of the proposed mgtE promoter. This reporter strain was grown 
under various stress conditions (Table 4.4) and mgtE transcription was measured by beta-
galactosidase activity. Treatment with 5X M63 salts resulted in increased beta 
galactosidase activity, while 20% glucose and growth at 550Cinhibited transcription. 
Activity after treatment with 10% ethanol, 100 mM KCl, and 100 mM MgSO4 remained 
unchanged compared to untreated controls. This data indicates that mgtE transcription is 
upregulated only under very specific types of stresses and may not be part of a 
generalized stress response pathway in P. aeruginosa.  
Table 4.4. Activity of PmgtE-lacZ under various stresses. Values represent average of at 
least 3 independent experiments (+/- standard deviation). ns= not significant, compared to 
untreated 
Stress Condition Miller Units Significance 
Untreated 469 (+/-109)  
10% Ethanol 460 (+/-66) ns 
100 mM KCl 543 (+/-98) ns 
100 mM MgSO4 460 (+/-142) ns 
20% Glucose 244 (+/-81) p<0.05 
5X M63 Salts 870 (+/-183) p<0.05 
550C 176 (+/-92) p<0.05 
 
algR genetically interact with mgtE to affect T3SS gene transcription in P. aeruginosa. 
A previous study from our lab showed that algR abrogates the cytotoxicity phenotype of 
mgtE (Fig. 1.2) (2). To investigate the mechanism behind this observation, we tested 
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whether this effect on cytotoxicity is mediated through effects on T3SS gene transcription; 
cytotoxicity in P. aeruginosa, in large part, is due to the T3SS (91). For this experiment, 
we used the previously described PexsD-lacZ T3SS transcriptional reporter in P. aeruginosa 
(see Chapter 3) and assayed the effects of the WT, ∆mgtE, ∆algR and ∆mgtE/∆algR on 
T3SS gene transcription. As evident from Fig 4.1, mutation in algR disrupts the enhancing 
effect of the mgtE mutant on T3SS gene transcription, indicating that the effect of the 
∆mgtE/∆algR double mutant on cytotoxicity in P. aeruginosa is likely mediated through 
effects on T3SS gene transcription. To further elucidate the nature of the algR-mgtE genetic 
crosstalk, we tested whether expression of mgtE in a ΔalgZR mutant can inhibit T3SS gene 
transcription, like that in the WT P. aeruginosa (Chapter 3). mgtE still significantly 
reduced PexsD-lacZ reporter values even in the ΔalgZR mutant (Fig 4.2), indicating complex 
genetic interaction between mgtE and algR.  
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Figure 4.1. Mutation in algR disrupts the enhancing effect of the mgtE mutant on T3SS 
gene transcription.  
For examining the T3SS promoter activity in the PA14 strain under different mutant 
conditions, beta-galactosidase activity (Miller units) was measured from the PexsD–lacZ 
construct in the WT, ∆mgtE, ∆algR and ∆mgtE/∆algR strains grown as planktonic, broth 
cultures. The data are representative of five independent experiments. *p<0.05, compared 
to WT; #p<,0.05, compared to all other strains.  
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Figure 4.2. mgtE inhibits T3SS gene transcription in a ∆algZR background.  
∆algZR strains with either vector control or pmgtE were assayed under T3SS inducing 
(+EGTA) conditions for beta-galactosidase activity from the PexsD-lacZ reporter construct. 
Percent activity was calculated considering the PexsD-lacZ activity in the ∆algZR strain with 
blank vector as 100%. *p<0.0005. 
 
The ∆mgtE/∆algR mutation does not inhibit transcription from the proximal PexsA 
promoter. As mentioned in Chapter 3, ExsA is transcribed from a polycistronic operon 
and it regulates its own expression from the PexsC promoter. However, there is a small 
proximal promoter PexsA immediately upstream of the exsA gene that is independent of 
ExsA. Since the ∆mgtE/∆algR mutation inhibits T3SS gene transcription, one possibility 
is that this double mutation inhibits exsA transcription from the proximal promoter PexsA. 
To test this possibility, we assayed whether the ∆mgtE/∆algR mutation reduced lacZ 
expression from the PexsA-lacZ transcriptional reporter, as compared to what is seen in the 
WT. As shown in Fig. 4.3, the ∆mgtE/∆algR mutation does not inhibit exsA transcription 
from the PexsA promoter. 
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Figure 4.3. ∆mgtE/∆algR does not inhibit exsA transcription from the PexsA promoter. 
WT and ∆mgtE/∆algR mutant strains were assayed under T3SS inducing (+EGTA) 
conditions for beta-galactosidase activity (expressed as Miller units) from the PexsA-lacZ 
reporter construct. n.s.=not significant. 
 
algR is an inhibitor of mgtE transcription. To further analyze the relationship between 
MgtE and AlgR, we investigated whether mutation of one gene led to altered expression 
of the other. Toward that end, we generated lacZ transcriptional fusions to the putative 
promoters of mgtE and algR, as described in Material and Methods, and measured beta-
galactosidase production in WT and mutant strains. In this manner, we found little 
difference in algR promoter activity between WT and ΔmgtE strains (Fig. 4.4A). However, 
transcription from the mgtE promoter was greatly enhanced by mutation of algR compared 
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to the WT strain (Fig. 4.4B). Interestingly, in silico analysis found a putative AlgR binding 
sequence around 65 bases upstream of the mgtE start codon (Fig 4.5A). To further 
investigate whether AlgR represses mgtE transcription by directly binding to the mgtE 
promoter region, electrophoretic mobility shift assay (EMSA) was performed (courtesy Dr. 
Michael Schurr, University of Colorado) using a phosphomimetic AlgR (AlgRD54E) 
which has a high affinity for DNA binding and the oligonucleotide 5’-
CAGTTTCCCGTTTGACCAATCAC-3’, which represents the segment of the mgtE 
promoter region containing the putative AlgR binding sequence (Fig. 4.5B). The AlgR 
binding site in the algD promoter region (164) was used as the positive control (Fig. 4.5C). 
There appears to be a faint bandshift when 10µM AlgRD54E is used (Fig. 4.5B), indicating 
that AlgR directly binds, albeit weakly, to the mgtE promoter region in vitro.  
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Figure 4.4. AlgR negatively regulates mgtE promoter activity.  
(A) Beta-Galactosidase activity (Miller units) was measured from the PalgR–lacZ construct 
in the WT and ∆mgtE strains grown as planktonic, broth cultures. Data are representative 
of three independent experiments, each containing triplicate or quadruplicate samples. (B) 
Transcriptional activity of the mgtE promoter was analyzed by the beta-galactosidase assay 
(Miller units) using the PmgtE–lacZ construct in the WT and ∆algR strains grown as 
planktonic, broth cultures. Data are representative of three independent experiments, each 
containing triplicate or quadruplicate samples. *p<0.05, compared to WT. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
 
 
Figure 4.5. AlgR weakly binds to the mgtE promoter region.  
(A) In silico analysis reveals a putative AlgR binding site (shown in bold) in the mgtE 
promoter region. The mgtE start codon is demarcated by large font. (B) EMSA was 
performed using varying concentrations (0.15-10µM) of purified AlgRD54E protein with 
the oligonucleotide containing the putative AlgR binding site in the mgtE promoter or with 
the oligonucleotide containing the AlgR binding site in the algD promoter (C). 50nm 
oligonucleotide was used in both experiments. The base pairs in the putative AlgR binding 
region in the mgtE promoterthat are mismatched from the consensus AlgR binding 
sequence are marked in red. The faint bandshift highlighted with the box is indicative of 
weak but direct binding of AlgR to the putative binding site in the mgtE promoter. 
(Courtesy Dr. Michael Schurr).  
 
Examination of other algR and mgtE regulated phenotypes. Since the genetic crosstalk 
between algR and mgtE was evident on regulation of T3SS gene transcription, we tested 
whether this genetic interaction affected other virulence phenotypes as well in P. 
aeruginosa. For this, we tested the effects of the WT, ∆mgtE, ∆algR and ∆mgtE/∆algR on 
twitching motility, rhamnolipid production and pyocyanin synthesis in P. aeruginosa. As 
shown in Fig 4.6, the mgtE-algR genetic interaction is not evident in regulation of these 
virulence phenotypes, indicating that this crosstalk is specifically directed towards T3SS 
regulation in P. aeruginosa. 
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Figure 4.6. Examination of other AlgR and MgtE regulated phenotypes.  
(A) Twitching motility was assessed for the individual mutants and for the ∆mgtE/∆algR 
double mutant, compared to WT. In the top panel, mean twitching zones for each strain are 
reported. *p<0.05, compared to WT and ∆mgtE. The bottom panel depicts representative 
images of crystal violet-stained twitch zones for each strain. (B) Rhamnolipid secretion of 
mutants was assessed by zone size of CTAB/rhamnolipid precipitant, compared to WT. In 
the top panel, mean zone size for each strain is reported. *p<0.05, compared to WT. The 
bottom panel depicts representative images of colonies and CTAB/rhamnolipid precipitant 
zones. (C) Pyocyanin production of WT and mutants was assessed as described in Methods. 
*p<0.05, compared to WT and ∆algR. 
 
4.4 Discussion 
MgtE, a magnesium transport protein, has been identified as a virulence modulatory protein 
in P. aeruginosa (91, 99), and a virulence and biofilm modulatory protein in several other 
bacteria (156, 157, 172). However, the regulation of mgtE and the environmental signals 
that influence mgtE transcription (and thus affect downstream virulence pathways) are 
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poorly understood. In previous studies, we found that mgtE could affect bacterial 
cytotoxicity through modulation of T3SS (99) and that tobramycin and various other 
antibiotic treatments resulted in a significant increase in mgtE transcript levels (91). 
Importantly, isogenic deletion of mgtE resulted in WT levels of antibiotic sensitivity (91), 
suggesting that mgtE induction might play only a minor role in antibiotic resistance. In 
accordance with these previous findings, we also observed that incubation in decreased 
levels of magnesium, which can stimulate mgtE transcription, has little effect on MIC 
(Table 4.3). Instead, we hypothesized that antibiotics act as signals that induce mgtE 
transcription, as part of an effort to downregulate production of factors associated with 
acute infections (e.g. T3SS) during biofilm development. 
 
AlgR is a regulatory protein that functions in many different pathways, most notably the 
alginate biosynthesis pathway. Induction of this pathway results in a mucoid P. aeruginosa 
phenotype, due to production of copious amounts of alginate. The mucoidy phenotype is 
evident during chronic infection of the CF airway and it enhances biofilm formation. AlgR 
is part of the AlgR–AlgZ two component regulatory system, which interacts with AlgU 
(92), the sigma factor that activates many genes essential for induction of the alginate 
pathway, including algR. Furthermore, algR is an important gene for P. aeruginosa 
pathogenesis, as an algR mutant is less virulent than a WT strain in an acute septicemia 
mouse model of infection (173). AlgR is also required for twitching motility, which is 
associated with increased virulence (174). 
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This evidence, as well as proteomic analysis of an algR mutant (173), suggests that AlgR 
is a global regulator impacting the expression of many different genes, including the T3SS 
genes. When AlgR is mutated, an increased expression of certain T3SS genes, such as exsA 
and exoS, is observed. ExsA is the master regulator for the T3SS in P. aeruginosa (55), 
and prior and recent findings (Chapter 3) suggest that MgtE may be indirectly affecting 
this protein to inhibit T3SS. Indeed, increased expression of mgtE leads to decreased T3SS 
production and lowered cytotoxicity. These results imply important but complex 
interactions of AlgR with other virulence pathways in P. aeruginosa. 
 
Our findings also support a possible interaction between algR and mgtE (Fig. 1.1), because 
deletion of algR in the ∆mgtE strain led to decreased transcription from the PexsD promoter 
(Fig. 4.1). Also, our results suggest that algR has negative regulatory effects on mgtE 
transcription (Fig. 4.4). Interestingly, in silico analysis has identified a putative AlgR 
binding site upstream of the mgtE promoter (Fig 4.5A). Further, in collaboration with Dr. 
Michael Schurr, we have identified a weak but direct binding of AlgR to the mgtE promoter 
in vitro (Fig 4.5B). Ongoing studies are aimed at further investigating this interaction 
between AlgR and the mgtE promoter. 
 
Altogether, these data imply that there is a peculiar cross-talk between algR and mgtE in 
regulating the T3SS, and this effect seems to be specific to T3SS (Fig. 4.6). Because 
reduction in T3SS is an important component of P. aeruginosa biofilms in the CF lung, 
these data support the hypothesis that mgtE can influence the biofilm phenotype in response 
to CF-relevant signals. We speculate that MgtE and AlgR both inhibit the function of a 
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T3SS repressor, either separately or in concert. In this scheme, mutation of either mgtE or 
algR is compensated by the presence of the other, but when both are mutated, high-level 
activity of the repressor prevents T3SS transcription and cytotoxicity (Fig 4.7). However, 
it is also possible that MgtE and AlgR could be acting independently on T3SS. Further 
studies are needed to fully characterize the relationship between these two proteins, and 
whether MgtE regulation of T3SS is mediated by the observed mgtE regulation by AlgR 
(Figs. 4.4 and 4.5). Among efforts directed at elucidating the nature of the algR-mgtE 
genetic interaction in P. aeruginosa, we are performing transcriptomic (RNAseq) and 
proteomic analysis of the WT, ∆mgtE, ∆algR, and ∆mgtE/∆algR strains. 
 
Figure 4.7. Hypothetical model to account for the inhibition of T3SS gene transcription in 
the ∆mgtE/∆algR strain of P. aeruginosa. 
AlgZR and the inner membrane (IM) Mg2+ transporter MgtE, by an unknown mechanism 
inhibits a third cryptic inhibitor (I), which inhibits T3SS gene expression. This inhibitor is 
inhibited by both mgtE and algR. Therefore, when both mgtE and algR are mutated, this 
inhibitor gets upregulated (synthetically or functionally) and inhibits T3SS gene 
transcription. Dashed red lines indicate inhibition. Additionally, AlgR, putatively by 
directly binding to the mgtE promoter, downregulates mgtE transcription, as we have 
shown in this Chapter.  
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Previous studies in our lab have clearly demonstrated that numerous antibiotics can 
enhance mgtE transcription, possibly as the result of activation of stress responses. Indeed, 
AlgR is regulated by the sigma E homologue AlgU, which responds to heat shock, among 
other envelope stresses. Thus, inhibition of mgtE transcription at 550C (Table 4.4) could 
be the result of repression by elevated levels of AlgR under these conditions. Additionally, 
it is possible that mgtE is activated by the stringent response (175), as evidenced by 
increased mgtE transcription in the nutrient-limited M63 medium (without carbon or amino 
acids sources) (Table 4.4). Enhanced mgtE expression could result in biofilm phenotype 
changes by decreasing T3SS (99) and possibly interacting with other known virulence 
pathways as shown in Chapter 3. A greater understanding of mgtE regulation could lead to 
novel methods of inhibiting biofilm formation and bacterial toxicity. Our data suggest that 
AlgR might act as a link between external signals like antibiotics and mgtE transcriptional 
responses. As we dissect the complex relationship between mgtE, biofilm formation and 
toxicity, we can devise novel methods for treatment of this recalcitrant microbe. 
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 FINAL DISCUSSION AND FUTURE 
PERSPECTIVES 
A major global health problem is the rise in antibiotic resistance in pathogenic bacteria 
(176). Pseudomonas aeruginosa is one of the antibiotic recalcitrant ESKAPE 
(Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter 
baumannii, Pseudomonas aeruginosa, and Enterobacter species) superbugs (177). 
Antibiotic-resistant P. aeruginosa is listed as one of the top 18 drug-resistant threats in the 
United States (listed as Hazard Level Serious) by the Centers for Disease Control and 
Prevention (178), and one of the top 12 Priority Pathogens for development of new 
antibiotics (Priority 1: Critical) by the World Health Organization (179). In addition to its 
inherent and acquired antibiotic resistance mechanisms, the capability to form clinically 
relevant biofilms is an important weapon possessed by P. aeruginosa, that renders it even 
more immune to antibiotic therapies. Though the regulatory pathways governing biofilm 
formation, maintenance, and dispersal in P. aeruginosa are diverse and complicated, the 
common feature is a reciprocal regulation between high cytotoxicity and increased biofilm 
forming lifestyles (88). It is important to elucidate these regulatory mechanisms to identify 
novel therapeutic targets in P. aeruginosa to both i) prevent it from forming antibiotic 
resistant biofilms and ii) reverting it to the planktonic lifestyle which is more susceptible 
to antibiotics. 
 
This current study describes two different mechanisms by which P. aeruginosa 
downregulates its cytotoxicity, thereby making it adapt to the biofilm lifestyle (Fig. 5.1). 
T3SS is a predominant feature behind cytotoxicity in P. aeruginosa (91). In Chapter 3, I 
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describe one molecular pathway through which mgtE inhibits the T3SS: through Rsm-
mediated translation inhibition of ExsA. These results largely illuminate cytotoxicity 
regulatory cascades in P. aeruginosa and once again confirm mgtE as a virulence regulator 
in P. aeruginosa. In Chapter 4, I have established algR as a regulator of mgtE expression 
and signaling, adding to its already reported pleiotropic role in P. aeruginosa. This AlgR 
data also suggest a second means for regulating T3SS: a potential unknown inhibitor that 
is inhibited by both AlgR and MgtE (Fig. 5.1). 
 
Figure 5.1. Pleiotropic effects of MgtE in P. aeruginosa pathogenesis. 
Low Mg2+ and high antibiotic conditions (as in CF lungs) activate mgtE transcription by an 
unknown mechanism. This results in higher levels of MgtE in the inner membrane (IM), 
which activates rsmY and rsmZ expression, through GacAS (Chapter 3), resulting in 
reduction in ExsA translation. AlgR, upon being phosphorylated by AlgZ, also activates 
RsmY and RsmZ expression (3). On the other hand, as discussed in Chapter 4, AlgR 
inhibits mgtE transcription. Also, AlgR and MgtE seem to simultaneously inhibit a third 
cryptic inhibitor (I), because of which a double mutation in algR and mgtE results in 
upregulation of this inhibitor and reduction in T3SS. Broken and solid green arrows depict 
activation by unknown and known mechanisms respectively; broken red lines indicate 
inhibition by a poorly understood mechanism.   
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It is unclear how these two pathways intersect to regulate T3SS. I have presented two key 
pieces of data to elucidate this issue. First, mgtE expression loses T3SS inhibiting effect in 
a Δrsm strain (Fig. 3.6), suggesting that mgtE acts exclusively through Rsm alone. It was 
recently shown that AlgR impacts T3SS activation by modulating the Rsm pathway (3), 
and it is tempting to speculate that MgtE figures into this process. However, our data (Fig 
4.2) demonstrate that T3SS transcription can be inhibited by mgtE expression even in a 
ΔalgR mutant. Thus, while it is possible that MgtE acts through an AlgR-mediated pathway 
to affect Rsm, and hence T3SS activation, this mechanism would likely be a minor activity. 
 
Alternatively, MgtE could impact T3SS through two separate avenues. In addition to 
inhibiting T3SS through a GacAS-Rsm pathway to decrease ExsA translation, MgtE could 
also be inhibiting a T3SS transcriptional inhibitor. In this scenario, AlgR would also be 
inhibiting this hypothetical inhibitor. Thus, mutation of either mgtE or algR could still lead 
to T3SS transcriptional enhancement, due to sequestration of the inhibitor by the other 
molecule, but deletion of both factors would lead to freeing of the inhibitor, resulting in 
T3SS downregulation (Fig. 4.7). 
 
In either case, we see a clear effect of decreased T3SS transcriptional activation upon mgtE 
expression. While there are numerous two-component, quorum sensing, adenylate cyclase, 
and other regulators that impact T3SS and biofilm establishment in P. aeruginosa, the 
signals that initiate these signaling cascades remain undefined. Research from our 
laboratory has shown that antibiotics as well as limiting magnesium conditions stimulate 
mgtE transcription. Furthermore, my research has shown that mgtE expression intimately 
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ties into the biofilm signaling networks (Fig. 3.7). Thus, we propose that limiting 
magnesium and high antibiotic levels are two factors that activate biofilm pathways, 
shifting the bacterium toward a chronic, biofilm lifestyle. Importantly, these are both 
signals present in the CF lung environment; patients are treated with high levels of 
antibiotics, and also exhibit decreased lung and serum magnesium levels, compared to non-
CF individuals (149, 150). Thus, MgtE could be a key factor modulating biofilm signaling 
during infections (Fig. 5.1). 
 
Future experiments would aim to further characterize mgtE expression and signaling in P. 
aeruginosa. Specifically, the precise protein-protein interactions that mediate mgtE 
regulation of GacASsignaling (Fig. 3.5) is an important milestone for research in our 
laboratory. Another important goal would be to characterize the mechanism behind algR-
driven mgtE transcription inhibition. Preliminary studies (Fig. 4.5) indicate that AlgR 
might be directly binding to the mgtE promoter. Ongoing studies to further characterize 
this DNA-protein interaction are underway. Also, it will be important to elucidate the exact 
mechanism behind the unique cytotoxicity inhibitory phenotype in the ΔalgR/ΔmgtE 
double mutant in P. aeruginosa. 
 
mgtE has been implicated as a virulence modulator in other organisms as well (106). Thus, 
the mechanism by which mgtE signals in these pathogens is an intriguing avenue for 
research. Interestingly, rsm homologues exist in some of the organisms where mgtE is 
implicated in pathogenesis (159). If future studies indicate that mgtE signals through a 
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conserved mechanism, that would set an important paradigm in membrane transporter 
biology. 
 
Given the role that mgtE plays in cytotoxicity regulation, it might be an interesting drug 
target, though extensive future studies are required to explore this proposition. Taken 
together, this research, provides clues for identification of novel therapeutic targets in P. 
aeruginosa. Drugs that modulate the biofilm phenotype (possibly through MgtE) such 
that bacteria emerge from the biofilm phenotype (and are thus killable) but maintain a 
low toxicity phenotype would revolutionize biofilm therapies. Thus, my work can serve 
as the foundation for studies to ameliorate the morbidity and mortality of patients 
affected by P. aeruginosa.   
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